Taussig Cancer Institute 2007 Publications Journal Publications Aboudola S, Murugesan G, Szpurka H, Ramsingh G, Zhao X, Prescott N, Tubbs RR, Maciejewski JP, Hsi ED. Bone marrow phospho-STAT5 expression in non-CML chronic myeloproliferative disorders correlates with JAK2 V617F mutation and provides evidence of in vivo JAK2 activation. Am J Surg Pathol. 2007 Feb;31(2):233-239. Adelstein DJ. Concurrent chemoradiotherapy in the management of squamous cell cancer of the oropharynx: current standards and future directions. Int J Radiat Oncol Biol Phys. 2007;69(2 Suppl):S37-S39. Adelstein DJ, Rice TW, Rybicki LA, Saxton JP, Videtic GMM, Murthy SC, Zuccaro G, Vargo JJ, Dumot JA, Carroll MA. A phase II trial of accelerated multimodality therapy for locoregionally advanced cancer of the esophagus and gastroesophageal junction: the impact of clinical heterogeneity. Am J Clin Oncol. 2007 Apr;30(2):172-180. Adiseshaiah P, Lindner DJ, Kalvakolanu DV, Reddy SP. FRA-1 proto-oncogene induces lung epithelial cell invasion and anchorage-independent growth in vitro, but is insufficient to promote tumor growth in vivo. Cancer Res. 2007 Jul 1;67(13):6204-6211. Aktas MK, Fleseriu M, Weil RJ, Faiman C, Sergev OT, Reddy S, Hamrahian AH. Graves disease exacerbation after pituitary adenomectomy for Cushing disease resulting in an adrenal crisis. Endocrinologist. 2007 Jul;17(4):206-208. Aldred MA, Machado RD, James V, Morrell NW, Trembath RC. Characterization of the BMPR2 5'-untranslated region and a novel mutation in pulmonary hypertension. Am J Respir Crit Care Med. 2007 Oct 15;176(8):819-824. Allen JD, Kennedy M, Wilson-Glover A, Gilligan TD. African-American men's perceptions about prostate cancer: implications for designing educational interventions. Soc Sci Med. 2007 Jun;64(11):2189-2200. Almhanna K, Kalmadi S, Pelley R, Kim R. Neoadjuvant therapy for hepatocellular carcinoma: is there an optimal approach? Oncology (Williston Park). 2007 Aug;21(9):1116- 1122; discussion 1122-1128. Alvarez-Breckenridge CA, Waite KA, Eng C. PTEN regulates phospholipase D and phospholipase C. Hum Mol Genet. 2007 May 15;16(10):1157-1163. Andersen JB, Li XL, Judge CS, Zhou A, Jha BK, Shelby S, Zhou L, Silverman RH, Hassel BA. Role of 2-5A-dependent RNase-L in senescence and longevity. Oncogene. 2007 May 10;26(21):3081-3088. Aron M, Kaouk JH, Hegarty NJ, Colombo JR Jr, Haber GP, Chung BI, Zhou M, Gill IS. Second prize: preliminary experience with the Niris optical coherence tomography system during laparoscopic and robotic prostatectomy. J Endourol. 2007 Aug;21(8):814-818. Aron M, Colombo JR Jr, Haber GP, Campbell SC, Gill IS. Laparoscopic radical cystectomy. BJU Int. 2007 Aug;100(2):455-476.
47
Embed
Taussig Cancer Institute 2007 Publications - Cleveland Clinic · Taussig Cancer Institute 2007 Publications Journal Publications ... Richter JE. Gastroesophageal ... Palazzo FF, Barontini
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Taussig Cancer Institute 2007 Publications
Journal Publications
Aboudola S, Murugesan G, Szpurka H, Ramsingh G, Zhao X, Prescott N, Tubbs RR, Maciejewski JP, Hsi ED. Bone marrow phospho-STAT5 expression in non-CML chronic
myeloproliferative disorders correlates with JAK2 V617F mutation and provides evidence of
in vivo JAK2 activation. Am J Surg Pathol. 2007 Feb;31(2):233-239.
Adelstein DJ. Concurrent chemoradiotherapy in the management of squamous cell cancer
of the oropharynx: current standards and future directions. Int J Radiat Oncol Biol Phys.
2007;69(2 Suppl):S37-S39.
Adelstein DJ, Rice TW, Rybicki LA, Saxton JP, Videtic GMM, Murthy SC, Zuccaro G, Vargo JJ, Dumot JA, Carroll MA. A phase II trial of accelerated multimodality therapy for
locoregionally advanced cancer of the esophagus and gastroesophageal junction: the
impact of clinical heterogeneity. Am J Clin Oncol. 2007 Apr;30(2):172-180.
Aldred MA, Machado RD, James V, Morrell NW, Trembath RC. Characterization of the BMPR2 5'-untranslated region and a novel mutation in pulmonary hypertension. Am J
Respir Crit Care Med. 2007 Oct 15;176(8):819-824.
Allen JD, Kennedy M, Wilson-Glover A, Gilligan TD. African-American men's perceptions about prostate cancer: implications for designing educational interventions. Soc Sci Med.
2007 Jun;64(11):2189-2200.
Almhanna K, Kalmadi S, Pelley R, Kim R. Neoadjuvant therapy for hepatocellular carcinoma: is there an optimal approach? Oncology (Williston Park). 2007 Aug;21(9):1116-
1122; discussion 1122-1128.
Alvarez-Breckenridge CA, Waite KA, Eng C. PTEN regulates phospholipase D and
phospholipase C. Hum Mol Genet. 2007 May 15;16(10):1157-1163.
Andersen JB, Li XL, Judge CS, Zhou A, Jha BK, Shelby S, Zhou L, Silverman RH, Hassel
BA. Role of 2-5A-dependent RNase-L in senescence and longevity. Oncogene. 2007 May
10;26(21):3081-3088.
Aron M, Kaouk JH, Hegarty NJ, Colombo JR Jr, Haber GP, Chung BI, Zhou M, Gill IS.
Second prize: preliminary experience with the Niris optical coherence tomography system
during laparoscopic and robotic prostatectomy. J Endourol. 2007 Aug;21(8):814-818.
Aron M, Colombo JR Jr, Haber GP, Campbell SC, Gill IS. Laparoscopic radical cystectomy. BJU Int. 2007 Aug;100(2):455-476.
Asosingh K, Swaidani S, Aronica M, Erzurum SC. Th1- and Th2-dependent endothelial
progenitor cell recruitment and angiogenic switch in asthma. J Immunol. 2007 May 15;178(10):6482-6494.
Sosman JA, Sukhatme VP, Vieweg JW, Wood CG, King L. Innovations and challenges in renal cell carcinoma: summary statement from the Second Cambridge Conference. Clin
Cancer Res. 2007 Jan 15;13(2 Pt 2):667s-670s.
Au A, Boehm CA, Mayes AM, Muschler GF, Griffith LG. Formation of osteogenic colonies on well-defined adhesion peptides by freshly isolated human marrow cells. Biomaterials.
2007 Apr;28(10):1847-1861.
Avigan DE, Vasir B, George DJ, Oh WK, Atkins MB, McDermott DF, Kantoff PW, Figlin RA,
Vasconcelles MJ, Xu Y, Kufe D, Bukowski RM. Phase I/II study of vaccination with electrofused allogeneic dendritic cells/autologous tumor-derived cells in patients with stage
IV renal cell carcinoma. J Immunother. 2007 Oct;30(7):749-761.
Babel N, Vergopoulos A, Trappe RU, Oertel S, Hammer MH, Karaivanov S, Schneider N, Riess H, Papp-Vary M, Neuhaus R, Gondek LP, Volk HD, Reinke P. Evidence for genetic
susceptibility towards development of posttransplant lymphoproliferative disorder in solid
organ recipients. Transplantation. 2007 Aug 15;84(3):387-391.
Baccala A, Sercia L, Li J, Heston W, Zhou M. Expression of prostate-specific membrane
antigen in tumor-associated neovasculature of renal neoplasms. Urology. 2007
Aug;70(2):385-390.
Baccala A Jr, Hedgepeth R, Kaouk J, Magi-Galluzzi C, Gilligan T, Fergany A. Pathological evidence of necrosis in recurrent renal mass following treatment with sunitinib. Int J Urol.
2007 Dec;14(12):1095-1097.
Baccala A Jr, Reuther AM, Bianco FJ Jr, Scardino PT, Kattan MW, Klein EA. Complete resection of seminal vesicles at radical prostatectomy results in substantial long-term
disease-free survival: multi-institutional study of 6740 patients. Urology. 2007
Mar;69(3):536-540.
Baker ME. Is barium column surface area a better predictor of primary achalasia disease severity than barium column height? Nat Clin Pract Gastroenterol Hepatol. 2007
Jun;4(6):308-309.
Baker ME, Einstein DM, Herts BR, Remer EM, Motta-Ramirez GA, Ehrenwald E, Rice TW, Richter JE. Gastroesophageal reflux disease: integrating the barium esophagram before
and after antireflux surgery. Radiology. 2007 May;243(2):329-339.
Baker ME, Bogoni L, Obuchowski NA, Dass C, Kendzierski RM, Remer EM, Einstein DM, Cathier P, Jerebko A, Lakare S, Blum A, Caroline DF, Macari M. Computer-aided detection
of colorectal polyps: can it improve sensitivity of less-experienced readers? Preliminary
findings. Radiology. 2007 Oct;245(1):140-149.
Bakri SJ, Singh AD, Lowder CY, Chalita MR, Li Y, Izatt JA, Rollins AM, Huang D. Imaging
of iris lesions with high-speed optical coherence tomography. Ophthalmic Surg Lasers
JA, Lindner DJ. Nitrosylcobalamin potentiates the anti-neoplastic effects of
chemotherapeutic agents via suppression of survival signaling. PLoS ONE. 2007 Dec
12;2(12):e1313.
Bausch B, Borozdin W, Mautner VF, Hoffmann MM, Boehm D, Robledo M, Cascon A,
Harenberg T, Schiavi F, Pawlu C, Peczkowska M, Letizia C, Calvieri S, Arnaldi G,
Klingenberg-Noftz RD, Reisch N, Fassina A, Brunaud L, Walter MA, Mannelli M, MacGregor G, Palazzo FF, Barontini M, Walz MK, Kremens B, Brabant G, Pfaffle R, Koschker AC,
Lohoefner F, Mohaupt M, Gimm O, Jarzab B, McWhinney SR, Opocher G, Januszewicz A,
Kohlhase J, Eng C, Neumann HPH. Germline NF1 mutational spectra and loss-of-heterozygosity analyses in patients with pheochromocytoma and neurofibromatosis type 1. J
Clin Endocrinol Metab. 2007 Jul;92(7):2784-2792.
Baz R, Walker E, Choueiri TK, Abou Jawde R, Brand C, McGowan B, Yiannaki E, Andresen
S, Hussein MA. Recombinant human erythropoietin is associated with increased overall survival in patients with multiple myeloma. Acta Haematol. 2007;117(3):162-167.
Baz R, Rodriguez C, Fu AZ, Abou Jawde R, Kalaycio M, Advani A, Sobecks R, Sekeres MA.
Impact of remission induction chemotherapy on survival in older adults with acute myeloid leukemia. Cancer. 2007 Oct 15;110(8):1752-1759.
Baz R, Fanning S, Kunkel L, Gaballa S, Karam MA, Reed J, Kelly M, Hussein M.
Combination of rituximab and oral melphalan and prednisone in newly diagnosed multiple
Bennett KL, Hackanson B, Smith LT, Morrison CD, Lang JC, Schuller DE, Weber F, Eng C, Plass C. Tumor suppressor activity of CCAAT/enhancer binding protein {alpha} is
epigenetically down-regulated in head and neck squamous cell carcinoma. Cancer Res.
2007 May 15;67(10):4657-4664.
Benson DM Jr, Elder PJ, Lin TS, Blum W, Penza S, Avalos B, Copelan E, Farag SS. High-
dose melphalan versus busulfan, cyclophosphamide, and etoposide as preparative
regimens for autologous stem cell transplantation in patients with multiple myeloma. Leuk Res. 2007 Aug;31(8):1069-1075.
Berglund RK, Sadetsky N, Duchane J, Carroll PR, Klein EA. Limited pelvic lymph node
dissection at the time of radical prostatectomy does not affect 5-year failure rates for low,
intermediate and high risk prostate cancer: Results from CaPSURE. J Urol. 2007 Feb;177(2):526-530.
Berk L, Berkey B, Rich T, Hrushesky W, Blask D, Gallagher M, Kudrimoti M, McGarry RC,
Suh J, Mehta M. Randomized phase II trial of high-dose melatonin and radiation therapy for RPA class 2 patients with brain metastases (RTOG 0119). Int J Radiat Oncol Biol Phys.
2007 Jul 1;68(3):852-857.
Bhattacharyya S, Mandal D, Sen GS, Pal S, Banerjee S, Lahiry L, Finke JH, Tannenbaum CS, Das T, Sa G. Tumor-induced oxidative stress perturbs nuclear factor-kappaB activity-
augmenting tumor necrosis factor-alpha-mediated T-cell death: protection by curcumin.
Cancer Res. 2007 Jan 1;67(1):362-370.
Bisbal C, Silverman RH. Diverse functions of RNase L and implications in pathology. Biochimie. 2007 Jun;89(6-7):789-798.
Blackstone EH, Rice TW. From trees to wood and back: perspective on clinical data
analysis in thoracic surgery. Thorac Surg Clin. 2007 Aug;17(3):309-327.
Bolwell BJ, Pohlman B, Rybicki L, Sobecks R, Dean R, Curtis J, Andresen S, Koo A, Mineff
V, Kalaycio M, Sweetenham JW. Patients mobilizing large numbers of CD34+ cells ('super
mobilizers') have improved survival in autologous stem cell transplantation for lymphoid
malignancies. Bone Marrow Transplant. 2007 Sep;40(5):437-441.
Borden EC. Melanoma 2007: current state and preview of the future. Semin Oncol. 2007
Dec;34(6):449-451.
Borden EC, Sen GC, Uze G, Silverman RH, Ransohoff RM, Foster GR, Stark GR. Interferons at age 50: past, current and future impact on biomedicine. Nat Rev Drug Discov.
2007 Dec;6(12):975-990.
Borden EC. Augmentation of effects of interferon-stimulated genes by reversal of epigenetic
Borden EC. Adult sarcomas: a missed opportunity for sustained cooperative group
translational and clinical research. Oncology (Williston Park). 2007 Feb;21(2):247-249.
Bowden SA, Sotos JF, Stratakis CA, Weil RJ. Successful treatment of an invasive growth hormone-secreting pituitary macroadenoma in an 8-year-old boy. J Pediatr Endocrinol
Metab. 2007 May;20(5):643-647.
Boyan BD, Schwartz Z, Patterson TE, Muschler G. Clinical use of platelet-rich plasma in orthopaedics. AAOS Now. 2007 Sep;1(7).
Bradley DA, Dunn R, Nanus D, Stadler W, Dreicer R, Rosenberg J, Smith DC, Hussain M.
Randomized, double-blind, placebo-controlled phase II trial of maintenance sunitinib versus placebo after chemotherapy for patients with advanced urothelial carcinoma: scientific
rationale and study design. Clin Genitourin Cancer. 2007 Dec;5(7):460-463.
Brouwers FM, Glasker S, Nave AF, Vortmeyer AO, Lubensky I, Huang S, Abu-Asab MS,
Eisenhofer G, Weil RJ, Park DM, Linehan WM, Pacak K, Zhuang Z. Proteomic profiling of von Hippel-Lindau syndrome and multiple endocrine neoplasia type 2 pheochromocytomas
reveals different expression of chromogranin B. Endocr Relat Cancer. 2007 Jun;14(2):463-
471.
Bukowski R, Cella D, Gondek K, Escudier B. Effects of sorafenib on symptoms and quality
of life: results from a large randomized placebo-controlled study in renal cancer. Am J Clin
Oncol. 2007 Jun;30(3):220-227.
Bukowski RM, Ozols RF, Markman M. The management of recurrent ovarian cancer. Semin
HA, Dutcher J, Ryba S, Xia Q, Scappaticci FA, McDermott D. Randomized phase II study of erlotinib combined with bevacizumab compared with bevacizumab alone in metastatic renal
cell cancer. J Clin Oncol. 2007 Oct 10;25(29):4536-4541.
Bukowski RM. Metastatic renal cell carcinoma: role of Mammalian target of rapamycin inhibitors. Clin Genitourin Cancer. 2007 Sep;5(6):359-361.
Burke CA, Church JM. Enhancing the quality of colonoscopy: the importance of bowel
Burke M, Anderson JR, Kao SC, Rodeberg D, Qualman SJ, Wolden SL, Meyer WH, Breitfeld PP. Assessment of response to induction therapy and its influence on 5-year
failure-free survival in group III rhabdomyosarcoma: the Intergroup Rhabdomyosarcoma
Study-IV experience--a report from the Soft Tissue Sarcoma Committee of the Children's Oncology Group. J Clin Oncol. 2007 Nov 1;25(31):4909-4913.
Burke ME, Albritton K, Marina N. Challenges in the recruitment of adolescents and young
adults to cancer clinical trials. Cancer. 2007 Dec 1;110(11):2385-2393.
Campbell SC. Editorial comment [Malignant ureteral obstruction: Outcomes after
intervention. Have things changed?]. J Urol. 2007 Jul;178(1):183.
Campbell SC. Editorial comment [A new staging system for locally advanced (pT3-4) renal
cell carcinoma: A Multicenter European Study including 2,000 patients]. J Urol. 2007
Aug;178(2):423.
Cannady SB, Batra PS, Leahy R, Citardi MJ, Janocha A, Ricci K, Comhair SAA, Bodine M, Wang Z, Hazen SL, Erzurum SC. Signal transduction and oxidative processes in sinonasal
Cannady SB, Batra PS, Sautter NB, Roh HJ, Citardi MJ. New staging system for sinonasal inverted papilloma in the endoscopic era. Laryngoscope. 2007 Jul;117(7):1283-1287.
Carpino F, Zborowski M, Williams PS. Quadrupole magnetic field-flow fractionation: A novel
technique for the characterization of magnetic nanoparticles. J Magn Magn Mater. 2007 Apr;311(1 SPEC. ISS.):383-387.
Cella D, Yount S, Brucker PS, Du H, Bukowski R, Vogelzang N, Bro WP. Development and
validation of a scale to measure disease-related symptoms of kidney cancer. Value Health.
2007 Jul;10(4):285-293.
Chang ASY, Smedira NG, Chang CL, Benavides MM, Myhre U, Feng J, Blackstone EH,
Lytle BW. Cardiac surgery after mediastinal radiation: extent of exposure influences
Chen M, Ogino T, Banerjee AK. Interaction of vesicular stomatitis virus P and N proteins: identification of two overlapping domains at the N terminus of P that are involved in N0-P
complex formation and encapsidation of viral genome RNA. J Virol. 2007 Dec;81(24):13478-
13485.
Cheng I, Plummer SJ, Casey G, Witte JS. Toll-like receptor 4 genetic variation and advanced prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2007 Feb;16(2):352-
355.
Cheng I, Krumroy LM, Plummer SJ, Casey G, Witte JS. MIC1 and IL1RN genetic variation and advanced prostate cancer risk. Cancer Epidemiol Biomarkers Prev. 2007
Jun;16(6):1309-1311.
Cheng I, Liu X, Plummer SJ, Krumroy LM, Casey G, Witte JS. COX2 genetic variation,
NSAIDs, and advanced prostate cancer risk. Br J Cancer. 2007 Aug 14;97(4):557-561.
Cheriyath V, Jacobs BS, Hussein MA. Proteasome inhibitors in the clinical setting: benefits
and strategies to overcome multiple myeloma resistance to proteasome inhibitors. Drugs R
D. 2007;8(1):1-12.
Cheriyath V, Glaser KB, Waring JF, Baz R, Hussein MA, Borden EC. G1P3, an IFN-induced survival factor, antagonizes TRAIL-induced apoptosis in human myeloma cells. J Clin
Invest. 2007 Oct;117(10):3107-3117.
Chiappori AA, Eckhardt SG, Bukowski R, Sullivan DM, Ikeda M, Yano Y, Yamada-Sawada T, Kambayashi Y, Tanaka K, Javle MM, Mekhail T, O'Bryant CL, Creaven PJ. A phase I
pharmacokinetic and pharmacodynamic study of s-3304, a novel matrix metalloproteinase
inhibitor, in patients with advanced and refractory solid tumors. Clin Cancer Res. 2007 Apr 1;13(7):2091-2099.
targeted therapy. Cancer. 2007 Aug 1;110(3):543-550.
Chung BJ, Batra PS, Citardi MJ, Lanza DC. Endoscopic septoplasty: revisitation of the
technique, indications, and outcomes. Am J Rhinol. 2007 May;21(3):307-311.
Chung EY, Liu J, Homma Y, Zhang Y, Brendolan A, Saggese M, Han J, Silverstein R,
Selleri L, Ma X. Interleukin-10 expression in macrophages during phagocytosis of apoptotic cells is mediated by homeodomain proteins Pbx1 and Prep-1. Immunity. 2007
Dec;27(6):952-964.
Citardi MJ, Batra PS. Intraoperative surgical navigation for endoscopic sinus surgery: rationale and indications. Curr Opin Otolaryngol Head Neck Surg. 2007 Feb;15(1):23-27.
Citardi MJ, Kanowitz SJ. A cadaveric model for balloon-assisted endoscopic paranasal
sinus dissection without fluoroscopy. Am J Rhinol. 2007 Sep;21(5):579-583.
Cohen D, Lane B, Jin T, Magi-Galluzzi C, Finke J, Rini BI, Bukowski RM, Zhou M. The prognostic significance of epidermal growth factor receptor expression in clear-cell renal cell
carcinoma: a call for standardized methods for immunohistochemical evaluation. Clin
Genitourin Cancer. 2007 Mar;5(4):264-270.
Cohen VML, Singh AD. Comments on: Basal cell carcinoma of the eyelids. Compr
Summers RW, Rothstein RI, Burke CA, Snover DC, Church TR, Allen JI, Robertson DJ, Beck GJ, Bond JH, Byers T, Mandel JS, Mott LA, Pearson LH, Barry EL, Rees JR, Marcon
N, Saibil F, Ueland PM, Greenberg ER. Folic acid for the prevention of colorectal
adenomas: a randomized clinical trial. JAMA. 2007 Jun 6;297(21):2351-2359.
Contado C, Dalpiaz A, Leo E, Zborowski M, Williams PS. Complementary use of flow and sedimentation field-flow fractionation techniques for size characterizing biodegradable
poly(lactic acid) nanospheres. J Chromatogr A. 2007 Jul 20;1157(1-2):321-335.
Copelan E, Casper JT, Carter SL, van Burik JAH, Hurd D, Mendizabal AM, Wagner JE, Yanovich S, Kernan NA. A scheme for defining cause of death and its application in the T
Cramer H, Okicki JR, Rho T, Wang X, Silverman RH, Heston WDW. 2-5A ligands - A new concept for the treatment of prostate cancer. Nucleosides Nucleotides Nucleic Acids.
2007;26(10):1471-1477.
Crosby ME, Jacobberger J, Gupta D, Macklis RM, Almasan A. E2F4 regulates a stable G(2)
arrest response to genotoxic stress in prostate carcinoma. Oncogene. 2007 Mar 22;26(13):1897-1909.
Xu M, Fox KR, Weinstein S, Orel SG, Vonderheide R, Coukos G, DeMichele A, Araujo L, Spitz FR, Rosen M, Levine BL, June C, Zhang PJ. Targeting HER-2/neu in early breast
cancer development using dendritic cells with staged interleukin-12 burst secretion. Cancer
Res. 2007 Feb 15;67(4):1842-1852.
Daneschvar HL, Daw H. Heparin-induced thrombocytopenia (an overview). Int J Clin Pract.
2007 Jan;61(1):130-137.
Danforth TL, Lane BR, Novick AC. Conservative management of giant symptomatic
angiomyolipomas in patients with the tuberous sclerosis complex. BJU Int. 2007 Oct;100(4):794-797.
Davis M, Maida V, Daeninck P, Pergolizzi J. The emerging role of cannabinoid
neuromodulators in symptom management. Support Care Cancer. 2007 Jan;15(1):63-71.
Davis M. Cholestasis and endogenous opioids : liver disease and exogenous opioid
Davis MP, Shaiova LA, Angst MS. When opioids cause pain. J Clin Oncol. 2007 Oct
1;25(28):4497-4498.
Davis MP. What is new in neuropathic pain? Support Care Cancer. 2007 Apr;15(4):363-
372.
Davis MP, Lasheen W, Gamier P. Practical guide to opioids and their complications in managing cancer pain. What oncologists need to know. Oncology (Williston Park). 2007
Sep;21(10):1229-1238; discussion 1238-1246,1249.
Davis MP. Orphanin FQ/nociceptin and morphine tolerance: Commentary. J Pain Palliat
Care Pharmacother. 2007;21(1):75-76.
Davis MP. Does trazodone have a role in palliating symptoms? Support Care Cancer. 2007
Feb;15(2):221-224.
Deprimo SE, Bello CL, Smeraglia J, Baum CM, Spinella D, Rini BI, Michaelson MD, Motzer
RJ. Circulating protein biomarkers of pharmacodynamic activity of sunitinib in patients with metastatic renal cell carcinoma: modulation of VEGF and VEGF-related proteins. J Transl
Med. 2007;5:32.
Dong B, Kim S, Hong S, Das Gupta J, Malathi K, Klein EA, Ganem D, Derisi JL, Chow SA, Silverman RH. From the Cover: An infectious retrovirus susceptible to an IFN antiviral
pathway from human prostate tumors. Proc Natl Acad Sci U S A. 2007 Jan 30;104(5):1655-
1660.
Dong F, Reuther AM, Magi-Galluzzi C, Zhou M, Kupelian PA, Klein EA. Pathologic stage
migration has slowed in the late PSA era. Urology. 2007 Nov;70(5):839-842.
KCM, Dickey DT, Muldoon LL, O'Neill BP, Peterson DR, Pollock B, Soussain C, Smith Q, Tyson RM, Neuwelt EA. Delivery of chemotherapy and antibodies across the blood-brain
barrier and the role of chemoprotection, in primary and metastatic brain tumors: report of the
Dowlati A, Subbiah S, Cooney M, Rutherford K, Mekhail T, Fu P, Chapman R, Ness A,
Cortas T, Saltzman J, Levitan N, Warren G. Phase II trial of thalidomide as maintenance therapy for extensive stage small cell lung cancer after response to chemotherapy. Lung
Cancer. 2007 Jun;56(3):377-381.
Downs-Kelly E, Schade AE, Hansel DE. The role of HLA-G in gastrointestinal inflammatory
disease and malignancy. Semin Cancer Biol. 2007 Dec;17(6):451-458.
Doyle DJ, Zura A, Ramachandran M, Lin J, Cywinski JB, Parker B, Marks T, Feldman M,
Lorenz RR. Airway management in a 980-lb patient: use of the Aintree intubation catheter.
J Clin Anesth. 2007 Aug;19(5):367-369.
Dreicer R, Petrylak D, Agus D, Webb I, Roth B. Phase I/II study of bortezomib plus
docetaxel in patients with advanced androgen-independent prostate cancer. Clin Cancer
Res. 2007 Feb 15;13(4):1208-1215.
Dreicer R, Li S, Manola J, Haas NB, Roth BJ, Wilding G. Phase 2 trial of epothilone B analog BMS-247550 (ixabepilone) in advanced carcinoma of the urothelium (E3800) : a trial
of the Eastern Cooperative Oncology Group. Cancer. 2007 Aug 15;110(4):759-763.
Dreicer R. Lenalidomide: immunomodulatory, antiangiogenic, and clinical activity in solid tumors. Curr Oncol Rep. 2007 Mar;9(2):120-123.
Dreicer R. Expert commentary [Young man with locally advanced prostate cancer]. Curr
Urol Rep. 2007 May;8(3):179-180.
Dreicer R. Chemotherapy for muscle-invasive bladder cancer in the perioperative setting:
Current standards. Urol Oncol. 2007 Jan;25(1):72-75.
Dreicer R. Biochemical failure in prostate cancer: Managing patients with limited data - The
alphavirus vaccine encoding prostate-specific membrane antigen elicits potent cellular and humoral immune responses. Clin Cancer Res. 2007 Jul 1;13(13):3999-4008.
Einhorn LH, Brames MJ, Dreicer R, Nichols CR, Cullen MT Jr, Bubalo J. Palonosetron plus
dexamethasone for prevention of chemotherapy-induced nausea and vomiting in patients receiving multiple-day cisplatin chemotherapy for germ cell cancer. Support Care Cancer.
2007 Nov;15(11):1293-1300.
Eng C. Robert J Gorlin, DDS, MS (1923-2006): a geneticist for all seasons. J Med Genet.
R, Stuehr DJ, Feelisch M, Beall CM. Higher blood flow and circulating NO products offset
high-altitude hypoxia among Tibetans. Proc Natl Acad Sci U S A. 2007 Nov 6;104(45):17593-17598.
Escobar PF, Patrick RJ, Rybicki LA, Weng DE, Crowe JP. The 2003 revised TNM Staging
System for Breast Cancer: Results of stage re-classification on survival and future comparisons among stage groups. Ann Surg Oncol. 2007 Jan;14(1):143-147.
P, Champagne P, Croteau D, Dupont E, Hariton C, Bukowski RM. Prognostic factors of metastatic renal cell carcinoma after failure of immunotherapy: new paradigm from a large
phase III trial with shark cartilage extract AE 941. J Urol. 2007 Nov;178(5):1901-1905.
The business of palliative medicine--part 5: service utilization in a comprehensive integrated program. Am J Hosp Palliat Care. 2007 Jun;24(3):211-218.
Estfan B, Mahmoud F, Shaheen P, Davis MP, Lasheen W, Rivera N, LeGrand SB, Lagman
RL, Walsh D, Rybicki L. Respiratory function during parenteral opioid titration for cancer pain. Palliat Med. 2007 Mar;21(2):81-86.
Faiman B. Clinical updates and nursing considerations for patients with multiple myeloma.
Clin J Oncol Nurs. 2007 Dec;11(6):831-840.
Falk GW. Night vision goggles for surveillance of Barrett's esophagus: a paradigm shift is
Appelbaum FR, Larson RA, Moore DF Jr, Tallman MS. Phase III trial of fludarabine plus
cyclophosphamide compared with fludarabine for patients with previously untreated chronic
lymphocytic leukemia: US Intergroup Trial E2997. J Clin Oncol. 2007 Mar 1;25(7):793-798.
Friedman AD, Dan O, Drazba JA, Lorenz RR, Strome M. Quantitative analysis of OX62-
positive dendritic cell distribution in the rat laryngeal complex. Ann Otol Rhinol Laryngol.
2007 Jun;116(6):449-456.
Friedman AD, Dan O, Drazba JA, Lorenz RR, Strome M. Postallograft donor and recipient
dendritic cell trafficking in the rat larynx. Laryngoscope. 2007 Sep;117(9):1615-1621.
Fukino K, Shen L, Patocs A, Mutter GL, Eng C. Genomic instability within tumor stroma and
clinicopathological characteristics of sporadic primary invasive breast carcinoma. JAMA. 2007 May 16;297(19):2103-2111.
Fukuyama R, Ng KP, Cicek M, Kelleher C, Niculaita R, Casey G, Sizemore N. Role of IKK
and oscillatory NFkappaB kinetics in MMP-9 gene expression and chemoresistance to 5-fluorouracil in RKO colorectal cancer cells. Mol Carcinog. 2007 May;46(5):402-413.
Furge KA, Tan MH, Dykema K, Kort E, Stadler W, Yao X, Zhou M, Teh BT. Identification of
deregulated oncogenic pathways in renal cell carcinoma: an integrated oncogenomic approach based on gene expression profiling. Oncogene. 2007 Feb 26;26(9):1346-1350.
Furmanczyk PS, Bruckner JD, Gillespy T III, Rubin BP. An unusual case of Erdheim-
Chester disease with features of Langerhans cell histiocytosis. Skeletal Radiol. 2007
Sep;36(9):885-889.
Galor A, Singh AD. Reply [Maculopathy as a complication of blood–brain barrier disruption
in patients with central nervous system lymphoma]. Am J Ophthalmol. 2007 Dec;144(6):976.
Galor A, Ference SJ, Singh AD, Lee MS, Stevens GHJ, Perez VL, Peereboom DM. Maculopathy as a complication of blood-brain barrier disruption in patients with central
nervous system lymphoma. Am J Ophthalmol. 2007 Jul;144(1):45-49.
Garcia JA, Rini BI. Recent progress in the management of advanced renal cell carcinoma. CA Cancer J Clin. 2007 Mar;57(2):112-125.
Garfield D, Hercbergs A, Davis P. Unanswered questions regarding the management of
Garfield DH, Hercbergs A, Davis PJ. Re: hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib. J Natl Cancer Inst. 2007 Jun 20;99(12):975-976.
Garland LL, Rankin C, Gandara DR, Rivkin SE, Scott KM, Nagle RB, Klein-Szanto AJP,
Testa JR, Altomare DA, Borden EC. Phase II study of erlotinib in patients with malignant pleural mesothelioma: a Southwest Oncology Group Study. J Clin Oncol. 2007 Jun
10;25(17):2406-2413.
George S, Bukowski RM. Biomarkers in clear cell renal cell carcinoma. Expert Rev Anticancer Ther. 2007 Dec;7(12):1737-1747.
Georgitsi M, Raitila A, Karhu A, Tuppurainen K, Makinen MJ, Vierimaa O, Paschke R,
Saeger W, van der Luijt RB, Sane T, Robledo M, De Menis E, Weil RJ, Wasik A, Zielinski G,
Lucewicz O, Lubinski J, Launonen V, Vahteristo P, Aaltonen LA. Molecular diagnosis of pituitary adenoma predisposition caused by aryl hydrocarbon receptor-interacting protein
gene mutations. Proc Natl Acad Sci U S A. 2007 Mar 6;104(10):4101-4105.
Giles F, Rizzieri D, Karp J, Vey N, Ravandi F, Faderl S, Khan KD, Verhoef G, Wijermans P, Advani A, Roboz G, Kantarjian H, Bilgrami SFA, Ferrant A, Daenen SMGJ, Karsten V, Cahill
A, Albitar M, Mufti G, O'Brien S. Cloretazine (VNP40101M), a novel sulfonylhydrazine
alkylating agent, in patients age 60 years or older with previously untreated acute myeloid
leukemia. J Clin Oncol. 2007 Jan 1;25(1):25-31.
Gill IS, Kavoussi LR, Lane BR, Blute ML, Babineau D, Colombo JR Jr, Frank I,
laparoscopic and open partial nephrectomies for single renal tumors. J Urol. 2007 Jul;178(1):41-46.
Gilligan T, Dreicer R. The atypical urothelial cancer patient: management of bladder
cancers of non-transitional cell histology and cancers of the ureters and renal pelvis. Semin Oncol. 2007 Apr;34(2):145-153.
Gilligan T. Testis cancer: rare, but curable with prompt referral. Cleve Clin J Med. 2007
Nov;74(11):817-825.
Golshayan AR, Bukowski RM. Is temsirolimus more safe and effective than interferon alpha for the treatment of advanced renal cell carcinoma? Nat Clin Pract Urol. 2007
Nov;4(11):586-587.
Golshayan AR, Jin T, Maciejewski J, Fu AZ, Bershadsky B, Kattan MW, Kalaycio ME, Sekeres MA. Efficacy of growth factors compared to other therapies for low-risk
Gondek LP, Dunbar AJ, Szpurka H, McDevitt MA, Maciejewski JP. SNP array karyotyping allows for the detection of uniparental disomy and cryptic chromosomal abnormalities in
MDS/MPD-U and MPD. PLoS ONE. 2007;2(11):e1225.
Gondek LP, Tiu R, Haddad AS, O'Keefe CL, Sekeres MA, Theil KS, Maciejewski JP. Single
nucleotide polymorphism arrays complement metaphase cytogenetics in detection of new chromosomal lesions in MDS. Leukemia. 2007 Sep;21(9):2058-2061.
Maciejewski JP. Detection of cryptic chromosomal lesions including acquired segmental uniparental disomy in advanced and low-risk myelodysplastic syndromes. Exp Hematol.
2007 Nov;35(11):1728-1738.
Gonzalez-Martinez JA, Bingaman WE, Toms SA, Najm IM. Neurogenesis in the postnatal human epileptic brain. J Neurosurg. 2007 Sep;107(3):628-635.
Gopan T, Toms SA, Prayson RA, Suh JH, Hamrahian AH, Weil RJ. Symptomatic pituitary
metastases from renal cell carcinoma. Pituitary. 2007;10(3):251-259.
Gorbachev AV, Kobayashi H, Kudo D, Tannenbaum CS, Finke JH, Shu S, Farber JM, Fairchild RL. CXC chemokine ligand 9/monokine induced by IFN-gamma production by
tumor cells is critical for T cell-mediated suppression of cutaneous tumors. J Immunol. 2007
Feb 15;178(4):2278-2286.
Gowans LK, Bentz ML, DeSantes KB, Thompson KJ. Successful treatment of an infant with
constitutional chromosomal abnormality and hemangiopericytoma with chemotherapy alone.
J Pediatr Hematol Oncol. 2007 Jun;29(6):409-411.
Green DM, Cotton CA, Malogolowkin M, Breslow NE, Perlman E, Miser J, Ritchey ML, Thomas PRM, Grundy PE, D'Angio GJ, Beckwith JB, Shamberger RC, Haase GM,
Donaldson M, Weetman R, Coppes MJ, Shearer P, Coccia P, Kletzel M, Macklis R,
Tomlinson G, Huff V, Newbury R, Weeks D. Treatment of Wilms tumor relapsing after initial treatment with vincristine and actinomycin D: A report from the National Wilms Tumor Study
Hamadani M, Martin LK, Benson DM, Copelan EA, Devine SM, Hofmeister CC. Central nervous system post-transplant lymphoproliferative disorder despite negative serum and
spinal fluid Epstein-Barr virus DNA PCR. Bone Marrow Transplant. 2007 Feb;39(4):249-251.
Han HS, Rybicki LA, Thiel K, Kalaycio ME, Sobecks R, Advani A, Brown S, Sekeres MA.
White blood cell count nadir following remission induction chemotherapy is predictive of outcome in older adults with acute myeloid leukemia. Leuk Lymphoma. 2007
Aug;48(8):1561-1568.
Han JQ, Townsend HL, Jha BK, Paranjape JM, Silverman RH, Barton DJ. A phylogenetically conserved RNA structure in the poliovirus open reading frame inhibits the
antiviral endoribonuclease RNase L. J Virol. 2007 Jun;81(11):5561-5572.
Han S, Wang G, Qiu S, de la Motte C, Wang HQ, Gomez G, Englander EW, Greeley GH Jr.
Increased colonic apelin production in rodents with experimental colitis and in humans with IBD. Regul Pept. 2007 Aug 16;142(3):131-137.
Hansel DE, Herawi M, Montgomery E, Epstein JI. Spindle cell lesions of the adult prostate.
Mod Pathol. 2007 Jan;20(1):148-158.
Hansel DE, Epstein JI, Berbescu E, Fine SW, Young RH, Cheville JC. Renal carcinoid
tumor: a clinicopathologic study of 21 cases. Am J Surg Pathol. 2007 Oct;31(10):1539-1544.
Hansel DE, Nadasdy T, Epstein JI. Fibromyxoid nephrogenic adenoma: a newly recognized
variant mimicking mucinous adenocarcinoma. Am J Surg Pathol. 2007 Aug;31(8):1231-1237.
Hansel DE, DeMarzo AM, Platz EA, Jadallah S, Hicks J, Epstein JI, Partin AW, Netto GJ.
Early prostate cancer antigen expression in predicting presence of prostate cancer in men
with histologically negative biopsies. J Urol. 2007 May;177(5):1736-1740.
Hansel DE, Jones JS. A critical appraisal of the classification of urothelial tumours: time for
a change, but not the change proposed. BJU Int. 2007 Dec;100(6):1213-1214; discussion
1214-1215.
Hauser K, Walsh D, Davis MP, Lagman RL, LeGrand SB. The pitfalls of visual analogue
scales in palliative medicine. European Journal of Palliative Care. 2007 May;14(3):99-102.
Heald B, Hilden JM, Zbuk K, Norton A, Vyas P, Theil KS, Eng C. Severe TMD/AMKL with GATA1 mutation in a stillborn fetus with Down syndrome. Nat Clin Pract Oncol. 2007
Jul;4(7):433-438.
Heald B, Moran R, Milas M, Burke C, Eng C. Familial adenomatous polyposis in a patient
with unexplained mental retardation. Nat Clin Pract Neurol. 2007 Dec;3(12):694-700.
Hercbergs A, Davis P. Hypothyroidism in the patient with cancer: how much thyroid
supplementation is "safe"? Arch Otolaryngol Head Neck Surg. 2007 Jun;133(6):625-626.
Hesketh PJ, Chansky K, Israel V, Grapski RT, Mekhail TM, Spiridonidis CH, Mills GM, Kelly
K, Crowley JJ, Gandara DR. Phase II study of gemcitabine and cisplatin in patients with previously untreated extensive stage small cell lung cancer: Southwest Oncology Group
Study 9718. J Thorac Oncol. 2007 May;2(5):440-444.
Hinson JT, Fantin VR, Schonberger J, Breivik N, Siem G, McDonough B, Sharma P, Keogh I, Godinho R, Santos F, Esparza A, Nicolau Y, Selvaag E, Cohen BH, Hoppel CL,
Tranebjaerg L, Eavey RD, Seidman JG, Seidman CE. Missense mutations in the BCS1L
gene as a cause of the Bjornstad syndrome. N Engl J Med. 2007 Feb 22;356(8):809-819.
Hsing JM, Thakkar SG, Borden EC, Budd GT. Intimal pulmonary artery sarcoma presenting as dyspnea: case report. Int Semin Surg Oncol. 2007 Jun 29;4:14.
Ioachimescu AG, Makdissi A, Lichtin A, Zimmerman RS. Thyroid disease in patients with
idiopathic thrombocytopenia: a cohort study. Thyroid. 2007 Nov;17(11):1137-1142.
Jackson H, Muhammad O, Daneshvar H, Nelms J, Popescu A, Vogelbaum MA, Bruchez M,
Toms SA. Quantum dots are phagocytized by macrophages and colocalize with experimental gliomas. Neurosurgery. 2007 Mar;60(3):524-529.
Ruszkiewicz AR, Pollett AF, Redston M, Barker MA, Baron JA, Casey GR, Dowty JG, Giles
GG, Limburg P, Newcomb P, Young JP, Walsh MD, Thibodeau SN, Lindor NM, Lemarchand L, Gallinger S, Haile RW, Potter JD, Hopper JL, Jass JR. Pathology features in
bethesda guidelines predict colorectal cancer microsatellite instability: a population-based
study. Gastroenterology. 2007 Jul;133(1):48-56.
Jing Y, Moore LR, Schneider T, Williams PS, Chalmers JJ, Farag SS, Bolwell B, Zborowski
M. Negative selection of hematopoietic progenitor cells by continuous magnetophoresis.
Exp Hematol. 2007 Apr;35(4):662-672.
Jing Y, Moore LR, Williams PS, Chalmers JJ, Farag SS, Bolwell B, Zborowski M. Blood
progenitor cell separation from clinical leukapheresis product by magnetic nanoparticle
binding and magnetophoresis. Biotechnol Bioeng. 2007 Apr 15;96(6):1139-1154.
Jones GA, Butler J, Lieberman I, Schlenk R. Negative-pressure wound therapy in the treatment of complex postoperative spinal wound infections: complications and lessons
learned using vacuum-assisted closure. J Neurosurg Spine. 2007 May;6(5):407-411.
Jorgenson E, Deitcher SR, Cicek M, Liu X, Plummer S, Casey G, Witte JS. Plasminogen activator inhibitor type-1 (PAI-1) polymorphism 4G/5G is associated with prostate cancer
among men with a positive family history. Prostate. 2007 Feb 1;67(2):172-177.
Kalakonda S, Nallar SC, Gong P, Lindner DJ, Goldblum SE, Reddy SP, Kalvakolanu DV.
Tumor suppressive protein gene associated with retinoid-interferon-induced mortality (GRIM)-19 inhibits src-induced oncogenic transformation at multiple levels. Am J Pathol.
2007 Oct;171(4):1352-1368.
Kalakonda S, Nallar SC, Lindner DJ, Hu J, Reddy SP, Kalvakolanu DV. Tumor-suppressive activity of the cell death activator GRIM-19 on a constitutively active signal transducer and
activator of transcription 3. Cancer Res. 2007 Jul 1;67(13):6212-6220.
Kalaycio M, Rybicki L, Pohlman B, Dean R, Sweetenham J, Andresen S, Sobecks R, Sekeres MA, Advani A, Brown S, Bolwell B. Elevated lactate dehydrogenase is an adverse
predictor of outcome in HLA-matched sibling bone marrow transplant for acute myelogenous
leukemia. Bone Marrow Transplant. 2007 Oct;40(8):753-758.
Kalmadi S, Davis M, Dowlati A, O'Keefe S, Cline-Burkhardt M, Pelley RJ, Borden E, Dreicer
R, Bukowski R, Mekhail T. Phase I trial of three-weekly docetaxel, carboplatin and oral
lenalidomide (Revlimid) in patients with advanced solid tumors. Invest New Drugs. 2007
Jun;25(3):211-216.
Kalmadi S, Baz R, Mahindra A. Lenalidomide: The emerging role of a novel targeted agent
in malignancies. Drugs Today (Barc ). 2007 Feb;43(2):85-95.
Kang TY, Nichols P, Skinner E, Groshen S, Valin G, Ye W, Raghavan D. Functional heterogeneity of prostatic intraepithelial neoplasia: the duration of hormonal therapy
influences the response. BJU Int. 2007 May;99(5):1024-1027.
Kang TY, Rybicki LA, Bolwell BJ, Thakkar SG, Brown S, Dean R, Sekeres MA, Advani A, Sobecks R, Kalaycio M, Pohlman B, Sweetenham JW. Effect of prior rituximab on high-
dose therapy and autologous stem cell transplantation in follicular lymphoma. Bone Marrow
Transplant. 2007 Nov;40(10):973-978.
Kantarjian H, Giles F, List A, Lyons R, Sekeres MA, Pierce S, Deuson R, Leveque J. The incidence and impact of thrombocytopenia in myelodysplastic syndromes. Cancer. 2007
May 1;109(9):1705-1714.
Kapural L, Mekhail N, Bena J, McLain R, Tetzlaff J, Kapural M, Mekhail M, Polk S. Value of the magnetic resonance imaging in patients with painful lumbar spinal stenosis (LSS)
Kapural L, Mekhail N. Novel intradiscal biacuplasty (IDB) for the treatment of lumbar discogenic pain. Pain Pract. 2007 Jun;7(2):130-134.
Kapural L, Stillman M, Kapural M, McIntyre P, Guirgius M, Mekhail N. Botulinum toxin
occipital nerve block for the treatment of severe occipital neuralgia: a case series. Pain
Pract. 2007 Dec;7(4):337-340.
Kefer JC, Cherullo EE, Jones JS, Gong MC, Campbell SC. Prostate-sparing cystectomy:
has Pandora's box been opened? Expert Rev Anticancer Ther. 2007 Jul;7(7):1003-1014.
Kelley T, Beck R, Absi A, Jin T, Pohlman B, Hsi E. Biologic predictors in follicular lymphoma: Importance of markers of immune response. Leuk Lymphoma. 2007
Dec;48(12):2403-2411.
Kelley TW, Pohlman B, Elson P, Hsi ED. The ratio of FOXP3+ regulatory T cells to
granzyme B+ cytotoxic T/NK cells predicts prognosis in classical Hodgkin lymphoma and is independent of bcl-2 and MAL expression. Am J Clin Pathol. 2007 Dec;128(6):958-965.
DP, Benson MC, Partin AW, Garrett-Mayer E, Eisenberger MA. Adjuvant weekly docetaxel for patients with high risk prostate cancer after radical prostatectomy: a multi-institutional
pilot study. J Urol. 2007 May;177(5):1777-1781.
Kim JY, Yoon JK, Citardi MJ, Batra PS, Roh HJ. The prevalence of human papilloma virus
infection in sinonasal inverted papilloma specimens classified by histological grade. Am J Rhinol. 2007 Nov;21(6):664-669.
Kim R, Saif MW. Is there an optimal neoadjuvant therapy for locally advanced pancreatic
cancer? JOP. 2007 May 9;8(3):279-288.
Kirkova J, Walsh D. Cancer symptom clusters-a dynamic construct. Support Care Cancer.
2007 Sep;15(9):1011-1013.
Klein EA. SELECTing the best. J Urol. 2007 Feb;177(2):428-429.
Klein EA. Promise for patients with metastatic renal cell carcinoma. Nat Clin Pract Urol.
2007 Feb;4(2):72-73.
Klein EA, Yang C, Kazanietz MG, Assoian RK. NFkappaB-independent signaling to the
cyclin D1 gene by Rac. Cell Cycle. 2007 May;6(9):1115-1121.
Klein EA, Abouassaly R. Experts' summay [Re: Survival of men with clinically localized
prostate cancer treated with prostatectomy, brachytherapy, or no definitive treatment:
Impact of age at diagnosis]. Eur Urol. 2007 Jun;51(6):1752.
Klein EA. Editorial comment [Quality of life for men receiving a second treatment for
ADAMTSL3/punctin-2, a gene frequently mutated in colorectal tumors, is widely expressed in normal and malignant epithelial cells, vascular endothelial cells and other cell types, and
its mRNA is reduced in colon cancer. Int J Cancer. 2007 Oct 15;121(8):1710-1716.
Gershoni-Baruch R, Eisen A, Daly M, Karlan B, Saal HM, Couch F, Pasini B, Wagner T,
Friedman E, Rennert G, Eng C, Weitzel J, Sun P, Narod SA, Garber J, Osborne M, Fishman
D, McLennan J, McKinnon W, Merajver S, Olsson H, Provencher D, Pasche B, Evans G, Meschino WS, Lemire E, Chudley A, Rayson D, Bellati C. Age at first birth and the risk of
breast cancer in BRCA1 and BRCA2 mutation carriers. Breast Cancer Res Treat. 2007
Oct;105(2):221-228.
Koyfman SA, Agrawal M, Garrett-Mayer E, Krohmal B, Wolf E, Emanuel EJ, Gross CP.
Risks and benefits associated with novel phase 1 oncology trial designs. Cancer. 2007 Sep
1;110(5):1115-1124.
Kundranda MN, Muslimani A, Daw HA, Spiro TP. Complete remission of metastatic
carcinoma of the prostate with bicalutamide withdrawal. Clin Genitourin Cancer. 2007
Sep;5(6):401-402.
Kundranda MN, Spiro TP, Muslimani A, Gopalakrishna KV, Melaragno MJ, Daw HA. Cerebral nocardiosis in a patient with NHL treated with rituximab. Am J Hematol. 2007
Nov;82(11):1033-1034.
Kupelian P, Willoughby T, Mahadevan A, Djemil T, Weinstein G, Jani S, Enke C, Solberg T, Flores N, Liu D, Beyer D, Levine L. Multi-institutional clinical experience with the Calypso
System in localization and continuous, real-time monitoring of the prostate gland during
external radiotherapy. Int J Radiat Oncol Biol Phys. 2007 Mar 15;67(4):1088-1098.
Kupelian PA, Willoughby TR, Reddy CA, Klein EA, Mahadevan A. Hypofractionated intensity-modulated radiotherapy (70 Gy at 2.5 Gy per fraction) for localized prostate cancer:
Cleveland Clinic experience. Int J Radiat Oncol Biol Phys. 2007 Aug 1;68(5):1424-1430.
Lagman R, Rivera N, Walsh D, LeGrand S, Davis MP. Acute inpatient palliative medicine in a cancer center: clinical problems and medical interventions--a prospective study. Am J
Hosp Palliat Care. 2007 Jan;24(1):20-28.
Lagman RL, LeGrand SB, Walsh D, Davis MP. The underutilization of palliative medicine services in the acute care setting. J Palliat Med. 2007 Aug;10(4):837-838.
Lagman RL, Walsh D, Davis MP, Young B. All patient refined-diagnostic related group and
case mix index in acute care palliative medicine. J Support Oncol. 2007 Mar;5(3):145-149.
Lagman RL, Walsh D. Acute care palliative medicine - The Cleveland model. European
Journal of Palliative Care. 2007 Jan;14(1):17-20.
Lagwinski N, Thomas A, Stephenson AJ, Campbell S, Hoschar AP, El-Gabry E, Dreicer R,
Hansel DE. Squamous cell carcinoma of the bladder: a clinicopathologic analysis of 45 cases. Am J Surg Pathol. 2007 Dec;31(12):1777-1787.
Lanas A, Baron JA, Sandler RS, Horgan K, Bolognese J, Oxenius B, Quan H, Watson D,
Cook TJ, Schoen R, Burke C, Loftus S, Niv Y, Ridell R, Morton D, Bresalier R. Peptic ulcer and bleeding events associated with rofecoxib in a 3-year colorectal adenoma
Lee BJ, Lowder CY, Biscotti C, Schoenfield L, Singh AD. Ciliary body metastasis
masquerading as scleritis. Br J Ophthalmol. 2007 Dec;91(12):1582,1649.
Li H, Rajendran GK, Liu N, Ware C, Rubin BP, Gu Y. SirT1 modulates the estrogen-insulin-
like growth factor-1 signaling for postnatal development of mammary gland in mice. Breast
Cancer Res. 2007;9(1):R1.
Li J, Lindner DJ, Farver C, Borden EC, Yi T. Efficacy of SSG and SSG/IFNalpha2 against human prostate cancer xenograft tumors in mice: a role for direct growth inhibition in SSG
anti-tumor action. Cancer Chemother Pharmacol. 2007 Aug;60(3):341-349.
Lieberman I. Surgery reduced pain and disability in lumbar spinal stenosis better than nonoperative treatment. J Bone Joint Surg Am. 2007 Aug;89(8):1872.
Lieberman I. Osteoporosis: a bare bones look. Provider. 2007 Sep;33(9):51-56.
Lietman SA, Barsoum WK, Goldblum JR, Marks KE, Mascha E, Sundaram M, Muschler G. A 20-year retrospective review of surgically treated liposarcoma at the Cleveland Clinic.
Orthopedics. 2007 Mar;30(3):227-234.
Lin AM, Rini BI, Derynck MK, Weinberg V, Park M, Ryan CJ, Rosenberg JE, Bubley G,
Small EJ. A phase I trial of docetaxel/estramustine/imatinib in patients with hormone-refractory prostate cancer. Clin Genitourin Cancer. 2007 Jun;5(5):323-328.
Is FDG-PET indicated for superficial esophageal cancer? Eur J Cardiothorac Surg. 2007 May;31(5):791-796.
Liu JY, Ren X, Yang X, Guo T, Yao Q, Li L, Dai X, Zhang M, Wang L, Liu M, Wang QK.
Identification of a novel GPR143 mutation in a large Chinese family with congenital nystagmus as the most prominent and consistent manifestation. J Hum Genet. 2007
Jun;52(6):565-570.
Liu W, Liang SL, Liu H, Silverman R, Zhou A. Tumour suppressor function of RNase L in a
Liu X, Cicek MS, Plummer SJ, Jorgenson E, Casey G, Witte JS. Association of testis
derived transcript gene variants and prostate cancer risk. J Urol. 2007 Mar;177(3):894-898.
Lo SS, Chang EL, Yamada Y, Sloan AE, Suh JH, Mendel E. Stereotactic radiosurgery and radiation therapy for spinal tumors. Expert Rev Neurother. 2007 Jan;7(1):85-93.
Lobry C, Weil R. Nouveaux mecanismes regulateurs de Bcl10 : une avancee dans la
comprehension de la survenue des lymphomes du MALT? [New Bcl10 regulation
mechanisms: a step in the comprehension of what has occurred in MALT lymphomas?] [French]. Med Sci (Paris). 2007 Apr;23(4):353-355.
Lockhart AC, Bukowski R, Rothenberg ML, Wang KK, Cooper W, Grover J, Appleman L,
Mayer PR, Shapiro M, Zhu AX. Phase I trial of oral MAC-321 in subjects with advanced malignant solid tumors. Cancer Chemother Pharmacol. 2007 Jul;60(2):203-209.
lymphadenitis. Arch Otolaryngol Head Neck Surg. 2007 Jul;133(7):729-731.
Lu T, Tian L, Han Y, Vogelbaum M, Stark GR. Dose-dependent cross-talk between the transforming growth factor-beta and interleukin-1 signaling pathways. Proc Natl Acad Sci U
S A. 2007 Mar 13;104(11):4365-4370.
Macconaill LE, Aldred MA, Lu X, Laframboise T. Toward accurate high-throughput SNP genotyping in the presence of inherited copy number variation. BMC Genomics. 2007;8:211.
Maciejewski JP, O'Keefe C, Gondek L, Tiu R. Immune-mediated bone marrow failure
syndromes of progenitor and stem cells: molecular analysis of cytotoxic T cell clones. Folia Histochem Cytobiol. 2007;45(1):5-14.
Mackley HB, Reddy CA, Lee SY, Harnisch GA, Mayberg MR, Hamrahian AH, Suh JH.
Intensity-modulated radiotherapy for pituitary adenomas: the preliminary report of the
Cleveland Clinic experience. Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):232-239.
Macklis RM. Radioimmunotherapy as a therapeutic option for non-Hodgkin's lymphoma.
Semin Radiat Oncol. 2007 Jul;17(3):176-183.
Magi-Galluzzi C, Zhou M, Reuther AM, Dreicer R, Klein EA. Neoadjuvant docetaxel treatment for locally advanced prostate cancer: a clinicopathologic study. Cancer. 2007 Sep
clinical applications: the 2005 International Apheresis Registry. Ther Apher Dial. 2007
Oct;11(5):341-362.
Marchi N, Angelov L, Masaryk T, Fazio V, Granata T, Hernandez N, Hallene K, Diglaw T, Franic L, Najm I, Janigro D. Seizure-promoting effect of blood-brain barrier disruption.
Epilepsia. 2007 Apr;48(4):732-742.
Margolis R, Budd GT, Singh AD. Unusual macular degeneration following breast cancer. Acta Ophthalmol Scand. 2007 Sep;85(6):686-687.
Marko NF, Weil RJ, Toms SA. Nanotechnology in proteomics. Expert Rev Proteomics. 2007
Oct;4(5):617-626.
Masci P, Olencki T, Wood L, Rybicki L, Jacobs B, Williams B, Faber P, Bukowski R, Tong K, Borden EC. Gene modulatory effects, pharmacokinetics, and clinical tolerance of interferon-
alpha1b: a second member of the interferon-alpha family. Clin Pharmacol Ther. 2007
Mar;81(3):354-361.
Masri FA, Xu W, Comhair SAA, Asosingh K, Koo M, Vasanji A, Drazba J, Anand-Apte B,
Erzurum SC. Hyperproliferative apoptosis-resistant endothelial cells in idiopathic pulmonary arterial hypertension. Am J Physiol Lung Cell Mol Physiol. 2007 Sep;293(3):L548-L554.
Mata A, Boehm C, Fleischman AJ, Muschler GF, Roy S. Connective tissue progenitor cell
growth characteristics on textured substrates. Int J Nanomedicine. 2007;2(3):389-406.
Matyakhina L, Bei TA, McWhinney SR, Pasini B, Cameron S, Gunawan B, Stergiopoulos SG, Boikos S, Muchow M, Dutra A, Pak E, Campo E, Cid MC, Gomez F, Gaillard RC, Assie
G, Fuzesi L, Baysal BE, Eng C, Carney JA, Stratakis CA. Genetics of carney triad: recurrent
losses at chromosome 1 but lack of germline mutations in genes associated with paragangliomas and gastrointestinal stromal tumors. J Clin Endocrinol Metab. 2007
Aug;92(8):2938-2943.
Mazumder S, Plesca D, Kinter M, Almasan A. Interaction of a cyclin e fragment with ku70 regulates bax-mediated apoptosis. Mol Cell Biol. 2007 May;27(9):3511-3520.
Mazumder S, Plesca D, Almasan A. A jekyll and hyde role of cyclin E in the genotoxic
stress response: switching from cell cycle control to apoptosis regulation. Cell Cycle. 2007
Jun 15;6(12):1437-1442.
Mazzone P, Obuchowski N, Mekhail T, Meziane M, Ahmad M. Lung cancer screening: is it
time for a change in policy? Cleve Clin J Med. 2007 Jun;74(6):441-448.
Mazzone PJ, Mekhail T. Lung cancer screening. Curr Oncol Rep. 2007 Jul;9(4):265-274.
Mazzone PJ, Hammel J, Dweik R, Na J, Czich C, Laskowski D, Mekhail T. Diagnosis of
lung cancer by the analysis of exhaled breath with a colorimetric sensor array. Thorax. 2007
Jul;62(7):565-568.
McCabe NP, De S, Vasanji A, Brainard J, Byzova TV. Prostate cancer specific integrin
alphavbeta3 modulates bone metastatic growth and tissue remodeling. Oncogene. 2007
Sep 13;26(42):6238-6243.
McClelland S III, Barnett GH, Neyman G, Suh JH. Repeat trigeminal nerve radiosurgery for refractory cluster headache fails to provide long-term pain relief. Headache. 2007
Merrill MM, Lane BR, Reuther AM, Zhou M, Magi-Galluzzi C, Klein EA. Tumor volume does
not predict for biochemical recurrence after radical prostatectomy in patients with surgical
Gleason score 6 or less prostate cancer. Urology. 2007 Aug;70(2):294-298.
Minai OA, Rigelsky C, Eng C, Arroliga AC, Stoller JK. Long-term outcome in a patient with
pulmonary hypertension and hereditary hemorrhagic telangiectasia. Chest. 2007 Apr;131(4):984-987.
Montgomery RB, Goldman B, Tangen CM, Hussain M, Petrylak DP, Page S, Klein EA,
Crawford ED. Association of body mass index with response and survival in men with
metastatic prostate cancer: Southwest Oncology Group trials 8894 and 9916. J Urol. 2007 Nov;178(5):1946-1951.
Moore HCF, Green SJ, Gralow JR, Bearman SI, Lew D, Barlow WE, Hudis C, Wolff AC,
Ingle JN, Chew HK, Elias AD, Livingston RB, Martino S. Intensive dose-dense compared with high-dose adjuvant chemotherapy for high-risk operable breast cancer: Southwest
Oncology Group/Intergroup study 9623. J Clin Oncol. 2007 May 1;25(13):1677-1682.
Moore HCF. Impact on quality of life of adjuvant therapy for breast cancer. Curr Oncol Rep. 2007 Jan;9(1):42-46.
Moore HCF, Theriault RL. Commentary: Ovarian function does not equal fertility does not
Moore WC, Bleecker ER, Curran-Everett D, Erzurum SC, Ameredes BT, Bacharier L, Calhoun WJ, Castro M, Chung KF, Clark MP, Dweik RA, Fitzpatrick AM, Gaston B, Hew M,
Hussain I, Jarjour NN, Israel E, Levy BD, Murphy JR, Peters SP, Teague WG, Meyers DA,
Busse WW, Wenzel SE. Characterization of the severe asthma phenotype by the National Heart, Lung, and Blood Institute's Severe Asthma Research Program. J Allergy Clin
Redman BG, Margolin KA, Wilding G. Sunitinib efficacy against advanced renal cell
carcinoma. J Urol. 2007 Nov;178(5):1883-1887.
Muhammad O, Popescu A, Toms SA. Macrophage-mediated colocalization of quantum
dots in experimental glioma. Methods Mol Biol. 2007;374:161-171.
Muldoon LL, Soussain C, Jahnke K, Johanson C, Siegal T, Smith QR, Hall WA, Hynynen K, Senter PD, Peereboom DM, Neuwelt EA. Chemotherapy delivery issues in central nervous
system malignancy: a reality check. J Clin Oncol. 2007 Jun 1;25(16):2295-2305.
Muslimani AA, Spiro TP, Chaudhry AA, Daw HA. Secondary myelodysplastic syndrome
after hydroxychloroquine therapy. Ann Hematol. 2007 Jul;86(7):531-534.
Muslimani AA, Kundranda M, Jain S, Daw HA. Recurrent bronchial epithelial-myoepithelial
carcinoma after local therapy. Clin Lung Cancer. 2007 May;8(6):386-388.
Muslimani AA, Ricaurte B, Daw HA. Immune heparin-induced thrombocytopenia resulting
from preceding exposure to heparin catheter flushes. Am J Hematol. 2007 Jul;82(7):652-655.
Muslimani AA, Kundranda MN, Daw HA. Chronic anemia due to parvovirus b19 infection in
a patient with multiple myeloma. Clin Adv Hematol Oncol. 2007 Jan;5(1):48-50.
Nagda SN, Mohideen N, Lo SS, Khan U, Dillehay G, Wagner R, Campbell S, Flanigan R.
Long-term follow-up of (111)In-capromab pendetide (ProstaScint) scan as pretreatment
assessment in patients who undergo salvage radiotherapy for rising prostate-specific antigen after radical prostatectomy for prostate cancer. Int J Radiat Oncol Biol Phys. 2007
Mar 1;67(3):834-840.
Narouze SN, Casanova J, Mekhail N. The longitudinal effectiveness of lateral atlantoaxial
intra-articular steroid injection in the treatment of cervicogenic headache. Pain Med. 2007 Mar;8(2):184-188.
Neumann HPH, Vortmeyer A, Schmidt D, Werner M, Erlic Z, Cascon A, Bausch B, Januszewicz A, Eng C. Evidence of MEN-2 in the original description of classic
pheochromocytoma. N Engl J Med. 2007 Sep 27;357(13):1311-1315.
Nguyen NP, Vos P, Karlsson U, Nguyen P, Dutta S, Lemanski C, Ludin A, Rose S, Nguyen
LM, Ward H, Huang S, Sallah S. Quality of life following chemoradiation and postoperative radiation for locally advanced head and neck cancer. ORL J Otorhinolaryngol Relat Spec.
Johnson PW. Low-dose lenograstim is as effective as standard dose in shortening neutrophil engraftment time following myeloablative chemotherapy and peripheral blood
Greenberg PL, Moore JO, Przepiorka D, Radich JP, Schilder RJ, Shami P, Smith BD, Snyder DS, Soiffer RJ, Tallman MS, Talpaz M, Wetzler M. Chronic myelogenous leukemia.
J Natl Compr Canc Netw. 2007 May;5(5):474-496.
O'Keefe CL, Gondek L, Davis R, Kuczkowski E, Sobecks RM, Rodriguez A, Narvaez Y, McIver Z, Tuthill R, Laughlin M, Bolwell B, Maciejewski JP. Molecular analysis of
alloreactive CTL post-hemopoietic stem cell transplantation. J Immunol. 2007 Aug
1;179(3):2013-2022.
O'Keefe CL, Tiu R, Gondek LP, Powers J, Theil KS, Kalaycio M, Lichtin A, Sekeres MA,
Maciejewski JP. High-resolution genomic arrays facilitate detection of novel cryptic
chromosomal lesions in myelodysplastic syndromes. Exp Hematol. 2007 Feb;35(2):240-251.
O'Leary N, Tiernan E, Walsh D, Lucey N, Kirkova J, Davis MP. The pitfalls of a systematic MEDLINE Review in palliative medicine: symptom assessment instruments. Am J Hosp
Palliat Care. 2007 Jun;24(3):181-184.
Obuchowski NA, Schoenhagen P, Modic MT, Meziane M, Budd GT. Incidence of advanced symptomatic disease as primary endpoint in screening and prevention trials. AJR Am J
Roentgenol. 2007 Jul;189(1):19-23.
Ochs-Balcom HM, Falk G, Grady WM, Kinnard M, Willis J, Elston R, Eng C, Chak A.
Consortium approach to identifying genes for Barrett's esophagus and esophageal adenocarcinoma. Transl Res. 2007 Jul;150(1):3-17.
Ogino A, Kitao H, Hirano S, Uchida A, Ishiai M, Kozuki T, Takigawa N, Takata M, Kiura K,
Tanimoto M. Emergence of epidermal growth factor receptor T790M mutation during chronic exposure to gefitinib in a non small cell lung cancer cell line. Cancer Res. 2007 Aug
15;67(16):7807-7814.
Ogino T, Banerjee AK. Unconventional mechanism of mRNA capping by the RNA-
dependent RNA polymerase of vesicular stomatitis virus. Mol Cell. 2007 Jan 12;25(1):85-97.
Olson WC, Heston WDW, Rajasekaran AK. Clinical trials of cancer therapies targeting
advances 2006: major research advances in cancer treatment, prevention, and screening--a
report from the American Society of Clinical Oncology. J Clin Oncol. 2007 Jan 1;25(1):146-162.
Palmieri D, Bronder JL, Herring JM, Yoneda T, Weil RJ, Stark AM, Kurek R, Vega-Valle E,
Feigenbaum L, Halverson D, Vortmeyer AO, Steinberg SM, Aldape K, Steeg PS. Her-2 overexpression increases the metastatic outgrowth of breast cancer cells in the brain.
Cancer Res. 2007 May 1;67(9):4190-4198.
Paner GP, Lindgren V, Jacobson K, Harrison K, Cao Y, Campbell SC, Flanigan RC, Picken
MM. High incidence of chromosome 1 abnormalities in a series of 27 renal oncocytomas: cytogenetic and fluorescence in situ hybridization studies. Arch Pathol Lab Med. 2007
Park DM, Li J, Okamoto H, Akeju O, Kim SH, Lubensky I, Vortmeyer A, Dambrosia J, Weil
RJ, Oldfield EH, Park JK, Zhuang Z. N-CoR pathway targeting induces glioblastoma derived cancer stem cell differentiation. Cell Cycle. 2007 Feb;6(4):467-470.
Pateder DB, Khanna AJ, Lieberman IH. Vertebroplasty and kyphoplasty for the
management of osteoporotic vertebral compression fractures. Orthop Clin North Am. 2007
Jul;38(3):409-418.
Patel AR, Jones JS, Zhou M, Schoenfield L, Magi-Galluzzi C. Parasagittal biopsies are
more important as part of an initial biopsy strategy than as part of a repeat biopsy strategy:
observations from a unique population. Prostate Cancer Prostatic Dis. 2007;10(4):352-355.
Patocs A, Zhang L, Xu Y, Weber F, Caldes T, Mutter GL, Platzer P, Eng C. Breast-cancer
stromal cells with TP53 mutations and nodal metastases. N Engl J Med. 2007 Dec
20;357(25):2543-2551.
Pezzolesi MG, Zbuk KM, Waite KA, Eng C. Comparative genomic and functional analyses reveal a novel cis-acting PTEN regulatory element as a highly conserved functional E-box
motif deleted in Cowden syndrome. Hum Mol Genet. 2007 May 1;16(9):1058-1071.
Pinzone JJ, Eng C, Paik J, Brindle KA, Ringel MD, Katz JD. A novel PTEN mutation in Cowden syndrome is associated with a mixed degenerative-erosive arthritic process:
Potential molecular pathogenic mechanisms. Am J Med Genet A. 2007 Jul 1;143(13):1522-
1527.
Plesca D, Crosby ME, Gupta D, Almasan A. E2F4 function in G2: maintaining G2-arrest to
prevent mitotic entry with damaged DNA. Cell Cycle. 2007 May;6(10):1147-1152.
Podrez EA, Byzova TV, Febbraio M, Salomon RG, Ma Y, Valiyaveettil M, Poliakov E, Sun
M, Finton PJ, Curtis BR, Chen J, Zhang R, Silverstein RL, Hazen SL. Platelet CD36 links
hyperlipidemia, oxidant stress and a prothrombotic phenotype. Nat Med. 2007
Sep;13(9):1086-1095.
Pogany A, Petersen M. What are the best screening instruments for PPD? JAAPA. 2007
Jul;20(7):34-38.
Ponsky LE, Mahadevan A, Gill IS, Djemil T, Novick AC. Renal radiosurgery: initial clinical experience with histological evaluation. Surg Innov. 2007 Dec;14(4):265-269.
Powell KA, Nakamoto C, Villarruel S, Boehm C, Muschler G. Quantitative image analysis of
Powell WC, Hicks DG, Prescott N, Tarr SM, Laniauskas S, Williams T, Short S, Pettay J,
Nagle RB, Dabbs DJ, Scott KM, Brown RW, Grogan T, Roche PC, Tubbs RR. A new rabbit
monoclonal antibody (4B5) for the immunohistochemical (IHC) determination of the HER2
status in breast cancer: comparison with CB11, fluorescence in situ hybridization (FISH), and interlaboratory reproducibility. Appl Immunohistochem Mol Morphol. 2007 Mar;15(1):94-
Lindor N, Grove J, Newcomb P, Jass J, Young J, Potter JD, Haile RW, Duggan DJ, Le
Marchand L. Variants on 9p24 and 8q24 are associated with risk of colorectal cancer: results from the Colon Cancer Family Registry. Cancer Res. 2007 Dec 1;67(23):11128-
11132.
Prayson RA, Yoder BJ, Barnett GH. Epidermal growth factor receptor is not amplified in
schwannomas. Ann Diagn Pathol. 2007 Oct;11(5):326-329.
Pretorius RG, Belinson JL. Letter to the editor concerning Petignat et al.'s "Are self-
collected samples comparable to physician-collected cervical specimens for human
papillomavirus DNA testing? A systematic review and meta-analysis." Gynecol Oncol 2007;105(2): 530-535. Gynecol Oncol. 2007 Dec;107(3):595-596.
Pretorius RG, Bao YP, Belinson JL, Burchette RJ, Smith JS, Qiao YL. Inappropriate gold
standard bias in cervical cancer screening studies. Int J Cancer. 2007 Nov 15;121(10):2218-
Raj JU, Aliferis C, Caprioli RM, Cowley AW Jr, Davies PF, Duncan MW, Erle DJ, Erzurum
SC, Finn PW, Ischiropoulos H, Kaminski N, Kleeberger SR, Leikauf GD, Loyd JE, Martin TR, Matalon S, Moore JH, Quackenbush J, Sabo-Attwood T, Shapiro SD, Schnitzer JE,
Schwartz DA, Schwiebert LM, Sheppard D, Ware LB, Weiss ST, Whitsett JA, Wurfel MM,
Matthay MA. Genomics and proteomics of lung disease: conference summary. Am J Physiol Lung Cell Mol Physiol. 2007 Jul;293(1):L45-L51.
Rani MRS, Pandalai S, Shrock J, Almasan A, Ransohoff RM. Requirement of catalytically
active Tyk2 and accessory signals for the induction of TRAIL mRNA by IFN-beta. J Interferon Cytokine Res. 2007 Sep;27(9):767-780.
Raval G, Biswas S, Rayman P, Biswas K, Sa G, Ghosh S, Thornton M, Hilston C, Das T, Bukowski R, Finke J, Tannenbaum CS. TNF-{alpha} induction of GM2 expression on renal
cell carcinomas promotes T cell dysfunction. J Immunol. 2007 May 15;178(10):6642-6652.
Ray S, Shyam S, Fraizer GC, Almasan A. S-phase checkpoints regulate Apo2 ligand/TRAIL and CPT-11-induced apoptosis of prostate cancer cells. Mol Cancer Ther. 2007
Apr;6(4):1368-1378.
Raychaudhuri B, Han Y, Lu T, Vogelbaum MA. Aberrant constitutive activation of nuclear factor kappaB in glioblastoma multiforme drives invasive phenotype. J Neurooncol. 2007
Oct;85(1):39-47.
Ready NE, Lipton A, Zhu Y, Statkevich P, Frank E, Curtis D, Bukowski RM. Phase I study
of the farnesyltransferase inhibitor lonafarnib with weekly paclitaxel in patients with solid tumors. Clin Cancer Res. 2007 Jan 15;13(2 Pt 1):576-583.
Rice TW, Blackstone EH. Does a biologic prosthesis really reduce recurrence after laparoscopic paraesophageal hernia repair? Ann Surg. 2007 Dec;246(6):1116-1117.
Rini B, Kar S, Kirkpatrick P. Temsirolimus. Nat Rev Drug Discov. 2007 Aug;6(8):599-600.
Rini BI, McDermott D, Atkins M. What is standard initial systemic therapy in metastatic renal cell carcinoma? Clin Genitourin Cancer. 2007 Mar;5(4):256-263.
Rini BI. Vascular endothelial growth factor-targeted therapy in renal cell carcinoma: current
status and future directions. Clin Cancer Res. 2007 Feb 15;13(4):1098-1106.
Rini BI, Campbell SC. The evolving role of surgery for advanced renal cell carcinoma in the
era of molecular targeted therapy. J Urol. 2007 Jun;177(6):1978-1984.
Rini BI. Sorafenib in advanced renal cancer: a viewpoint by brian I. Rini. Drugs. 2007;67(3):484-485.
Rini BI. Response: Re: Hypothyroidism in patients with metastatic renal cell carcinoma
treated with sunitinib. J Natl Cancer Inst. 2007 Jun 20;99(12):976-977.
Rini BI, Tamaskar I, Shaheen P, Salas R, Garcia J, Wood L, Reddy S, Dreicer R, Bukowski
RM. Hypothyroidism in patients with metastatic renal cell carcinoma treated with sunitinib. J
Natl Cancer Inst. 2007 Jan 3;99(1):81-83.
Rini BI, Rathmell WK. Biological aspects and binding strategies of vascular endothelial
growth factor in renal cell carcinoma. Clin Cancer Res. 2007 Jan 15;13(2):741s-746s.
Risitano AM, Maciejewski JP, Selleri C, Rotoli B. Function and malfunction of hematopoietic
stem cells in primary bone marrow failure syndromes. Curr Stem Cell Res Ther. 2007 Jan;2(1):39-52.
Rixe O, Bukowski RM, Michaelson MD, Wilding G, Hudes GR, Bolte O, Motzer RJ, Bycott P,
Liau KF, Freddo J, Trask PC, Kim S, Rini BI. Axitinib treatment in patients with cytokine-refractory metastatic renal-cell cancer: a phase II study. Lancet Oncol. 2007 Nov;8(11):975-
984.
Roma AA, Magi-Galluzzi C, Zhou M. Differential expression of melanocytic markers in myoid, lipomatous, and vascular components of renal angiomyolipomas. Arch Pathol Lab
Med. 2007 Jan;131(1):122-125.
Rubin BP. Tenosynovial giant cell tumor and pigmented villonodular synovitis: a proposal
for unification of these clinically distinct but histologically and genetically identical lesions. Skeletal Radiol. 2007 Apr;36(4):267-268.
Rubin BP. Reply to Dr. Folpe's comments on the article "Tenosynovial giant cell tumor and
pigmented villonodular synovitis: a proposal for unification of these clinically distinct but histologically and genetically identical lesions". Skeletal Radiol. 2007 Sep;36(9):901.
Rubin BP, Goldblum JR. Pathology of soft tissue sarcoma. J Natl Compr Canc Netw. 2007
Apr;5(4):411-418.
Rubin BP, Fletcher CDM, Inwards C, Montag AG, Peabody T, Qualman SJ, Rosenberg AE, Wright JH, Weiss S, Krausz T. In reply [Protocols for the examination and reporting of bone
and soft tissue tumors]. Arch Pathol Lab Med. 2007 May;131(5):681-682.
Rubin BP, Heinrich MC, Corless CL. Gastrointestinal stromal tumour. Lancet. 2007 May 19;369(9574):1731-1741.
Rundle P, Singh AD, Rennie I. Proton beam therapy for iris melanoma: a review of 15
cases. Eye. 2007 Jan;21(1):79-82.
Sade B, Chahlavi A, Krishnaney A, Nagel S, Choi E, Lee JH. World Health Organization
Grades II and III meningiomas are rare in the cranial base and spine. Neurosurgery. 2007
Dec;61(6):1194-1198.
Sade B, Lee JH. Significance of the tentorial alignment in approaching the trigeminal nerve and the ventral petrous region through the suboccipital retrosigmoid technique. J Neurosurg.
2007 Nov;107(5):932-936.
Sade B, Lee JH. Recovery of low-frequency sensorineural hearing loss following resection of a greater superficial petrosal nerve schwannoma. Case report. J Neurosurg. 2007
Jul;107(1):181-184.
Saif MW, Kim R. Role of platinum agents in the management of advanced pancreatic cancer. Expert Opin Pharmacother. 2007 Nov;8(16):2719-2727.
Saif MW, Kim R. Incidence and management of cutaneous toxicities associated with
cetuximab. Expert Opin Drug Saf. 2007 Mar;6(2):175-182.
Salas RN, Finke JH, Rini BI. The intersection of sunitinib with the immunosuppressive microenvironment of renal cell carcinoma: Implications for future therapeutics. Targeted
Oncology. 2007 Oct;2(4):225-234.
Samant RS, Clark DW, Fillmore RA, Cicek M, Metge BJ, Chandramouli KH, Chambers AF, Casey G, Welch DR, Shevde LA. Breast cancer metastasis suppressor 1 (BRMS1) inhibits
osteopontin transcription by abrogating NF-kappaB activation. Mol Cancer. 2007 Jan 16;6:6.
Sautter NB, Citardi MJ, Batra PS. Minimally invasive resection of frontal recess/sinus inverted papilloma. Am J Otolaryngol. 2007 Jul;28(4):221-224.
Sautter NB, Cannady SB, Citardi MJ, Roh HJ, Batra PS. Comparison of open versus
endoscopic resection of inverted papilloma. Am J Rhinol. 2007 May;21(3):320-323.
Schoenfield L, Jones JS, Zippe CD, Reuther AM, Klein E, Zhou M, Magi-Galluzzi C. The incidence of high-grade prostatic intraepithelial neoplasia and atypical glands suspicious for
carcinoma on first-time saturation needle biopsy, and the subsequent risk of cancer. BJU
Int. 2007 Apr;99(4):770-774.
Scott C, Suh J, Stea B, Nabid A, Hackman J. Improved survival, quality of life, and quality-
adjusted survival in breast cancer patients treated with efaproxiral (Efaproxyn) plus whole-
brain radiation therapy for brain metastases. Am J Clin Oncol. 2007 Dec;30(6):580-587.
Segota E, Mekhail T, Olencki T, Hutson TE, Dreicer R, Wacker B, Osterwalder B, Elson P, Zhou M, Bukowski RM. Phase II trial of capecitabine and rHu-interferon-alpha-2a in patients
with metastatic renal cell carcinoma, limited efficacy, and moderate toxicity. Urol Oncol.
Sekeres MA. New data with arsenic trioxide in leukemias and myelodysplastic syndromes.
Clin Lymphoma Myeloma. 2007 Dec;8 Suppl 1:S7-S12.
Sekeres MA, Fu AZ, Maciejewski JP, Golshayan AR, Kalaycio ME, Kattan MW. A decision
analysis to determine the appropriate treatment for low-risk myelodysplastic syndromes.
Cancer. 2007 Mar 15;109(6):1125-1132.
Sengupta S, Kim KS, Berk MP, Oates R, Escobar P, Belinson J, Li W, Lindner DJ, Williams B, Xu Y. Lysophosphatidic acid downregulates tissue inhibitor of metalloproteinases, which
are negatively involved in lysophosphatidic acid-induced cell invasion. Oncogene. 2007 May
3;26(20):2894-2901.
Shen GQ, Li L, Girelli D, Seidelmann SB, Rao S, Fan C, Park JE, Xi Q, Li J, Hu Y, Olivieri O,
EF, Topol EJ, Wang QK. An LRP8 variant is associated with familial and premature coronary artery disease and myocardial infarction. Am J Hum Genet. 2007 Oct;81(4):780-
791.
Shen WH, Balajee AS, Wang J, Wu H, Eng C, Pandolfi PP, Yin Y. Essential role for nuclear
PTEN in maintaining chromosomal integrity. Cell. 2007 Jan 12;128(1):157-170.
Shields C, Singh A, Shields J. Use of optical coherence tomography in pediatric
Shipchandler TZ, Lorenz RR, McMahon J, Tubbs R. Supraclavicular lymphadenopathy due to silicone breast implants. Arch Otolaryngol Head Neck Surg. 2007 Aug;133(8):830-832.
Shoham M, Lieberman IH, Benzel EC, Togawa D, Zehavi E, Zilberstein B, Roffman M,
Bruskin A, Fridlander A, Joskowicz L, Brink-Danan S, Knoller N. Robotic assisted spinal surgery-from concept to clinical practice. Comput Aided Surg. 2007 Mar;12(2):105-115.
Short SM, Yoder BJ, Tarr SM, Prescott NL, Laniauskas S, Coleman KA, Downs-Kelly E,
Pettay JD, Choueiri TK, Crowe JP, Tubbs RR, Budd TG, Hicks DG. The expression of the
cytoskeletal focal adhesion protein paxillin in breast cancer correlates with HER2 overexpression and may help predict response to chemotherapy: a retrospective
immunohistochemical study. Breast J. 2007 Mar;13(2):130-139.
Shu S, Zheng R, Lee WT, Cohen PA. Immunogenicity of dendritic-turnor fusion hybrids and their utility in cancer immunotherapy. Crit Rev Immunol. 2007;27(5):463-483.
Shultz DB, Fuller JD, Yang Y, Sizemore N, Rani MRS, Stark GR. Activation of a subset of
genes by IFN-gamma requires IKKbeta but not interferon-dependent activation of NF-
Simmons MN, Stephenson AJ, Klein EA. Rebuttal from Authors re: Gunnar Aus. Second-line therapy after radical prostatectomy failure: For Whom? When? How? Eur Urol
Simmons MN, Stephenson AJ, Klein EA. Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy. Eur Urol. 2007
May;51(5):1175-1184.
Simpkins F, Belinson JL, Rose PG. Avoiding bevacizumab related gastrointestinal toxicity for recurrent ovarian cancer by careful patient screening. Gynecol Oncol. 2007
Oct;107(1):118-123.
Singh AD, Sisley K, Xu Y, Li J, Faber P, Plummer SJ, Mudhar HS, Rennie IG, Kessler PM,
Casey G, Williams BG. Reduced expression of autotaxin predicts survival in uveal melanoma. Br J Ophthalmol. 2007 Oct;91(10):1385-1392.
Singh AD, Terman S, Sculley L. Estimating choroidal melanoma volume: comparison of methods. Ophthalmology. 2007 Jun;114(6):1212-1214.
Singh LS, Berk M, Oates R, Zhao Z, Tan H, Jiang Y, Zhou A, Kirmani K, Steinmetz R,
Lindner D, Xu Y. Ovarian cancer G protein-coupled receptor 1, a new metastasis suppressor gene in prostate cancer. J Natl Cancer Inst. 2007 Sep 5;99(17):1313-1327.
Sizemore S, Cicek M, Sizemore N, Ng KP, Casey G. Podocalyxin increases the aggressive
phenotype of breast and prostate cancer cells in vitro through Its interaction with Ezrin.
Cancer Res. 2007 Jul 1;67(13):6183-6191.
Sloand EM, Read EJ, Scheinberg P, Tang Y, More K, Leitman SF, Maciejewski J, Young
NS. Mobilization, collection, and immunomagnetic selection of peripheral blood CD34 cells
in recovered aplastic anemia patients. Transfusion. 2007 Jul;47(7):1250-1253.
Small EJ, Tchekmedyian NS, Rini BI, Fong L, Lowy I, Allison JP. A pilot trial of CTLA-4
blockade with human anti-CTLA-4 in patients with hormone-refractory prostate cancer. Clin
Cancer Res. 2007 Mar 15;13(6):1810-1815.
Smith S, Sweetenham JW. Iodine 131 tositumomab in the treatment of non-Hodgkin's lymphoma. Future Oncol. 2007 Jun;3(3):255-262.
Smith SD, Bolwell BJ, Rybicki LA, Brown S, Dean R, Kalaycio M, Sobecks R, Andresen S,
Hsi ED, Pohlman B, Sweetenham JW. Autologous hematopoietic stem cell transplantation in peripheral T-cell lymphoma using a uniform high-dose regimen. Bone Marrow Transplant.
2007 Aug;40(3):239-243.
Sobecks RM, Ball EJ, Maciejewski JP, Rybicki LA, Brown S, Kalaycio M, Pohlman B,
Andresen S, Theil KS, Dean R, Bolwell BJ. Survival of AML patients receiving HLA-matched sibling donor allogeneic bone marrow transplantation correlates with HLA-Cw
ligand groups for killer immunoglobulin-like receptors. Bone Marrow Transplant. 2007
Apr;39(7):417-424.
Soin A, Kapural L, Mekhail N. Imaging for percutaneous vertebral augmentation. Tech Reg Anesth Pain Manag. 2007 Apr;11(2):90-94.
Solares CA, Citardi MJ, Budev M, Batra PS. Management of frontal sinus mucoceles with
posterior table erosion in the pretransplant cystic fibrosis population. Am J Otolaryngol. 2007 Mar;28(2):110-114.
Somanath PR, Kandel ES, Hay N, Byzova TV. Akt1 signaling regulates integrin activation,
matrix recognition, and fibronectin assembly. J Biol Chem. 2007 Aug 3;282(31):22964-22976.
Stephenson AJ, Kuritzky L, Campbell SC. Screening for urologic malignancies in primary
comparison of primary chemotherapy and retroperitoneal lymph node dissection for clinical stage IIA and IIB nonseminomatous germ cell testicular cancer. J Clin Oncol. 2007 Dec
10;25(35):5597-5602.
Stephenson AJ. Identifying patients at risk for prostate-cancer-specific mortality:
Bone formation following OP-1 implantation is improved by addition of autogenous bone marrow cells in a canine femur defect model. J Orthop Res. 2007 Oct;25(10):1333-1342.
Tamaskar I, Choueiri TK, Sercia L, Rini B, Bukowski R, Zhou M. Differential expression of
caveolin-1 in renal neoplasms. Cancer. 2007 Aug 15;110(4):776-782.
Tamaskar I, Bukowski RM. Bladder cancer and current evidence for treatment. Oncology
(Williston Park). 2007;21(14):1691,1694.
Tan A, Adelstein DJ, Rybicki LA, Saxton JP, Esclamado RM, Wood BG, Lorenz RR, Strome
M, Carroll MA. Ability of positron emission tomography to detect residual neck node disease in patients with head and neck squamous cell carcinoma after definitive chemoradiotherapy.
Arch Otolaryngol Head Neck Surg. 2007 May;133(5):435-440.
Teker AM, Lorenz RR, Lee WT, Murthy SC. Radiology quiz case 1. Tracheocele. Arch Otolaryngol Head Neck Surg. 2007 Sep;133(9):940-943.
Teresi RE, Zbuk KM, Pezzolesi MG, Waite KA, Eng C. Cowden syndrome-affected patients
with PTEN promoter mutations demonstrate abnormal protein translation. Am J Hum Genet. 2007 Oct;81(4):756-767.
Terry J, Saito T, Subramanian S, Ruttan C, Antonescu CR, Goldblum JR, Downs-Kelly E,
Corless CL, Rubin BP, van de Rijn M, Ladanyi M, Nielsen TO. TLE1 as a diagnostic
immunohistochemical marker for synovial sarcoma emerging from gene expression profiling studies. Am J Surg Pathol. 2007 Feb;31(2):240-246.
Thakur CS, Jha BK, Dong B, Das Gupta J, Silverman KM, Mao H, Sawai H, Nakamura AO,
Banerjee AK, Gudkov A, Silverman RH. Small-molecule activators of RNase L with broad-spectrum antiviral activity. Proc Natl Acad Sci U S A. 2007 Jun 5;104(23):9585-9590.
Thomas AA, Lane BR, Thomas AZ, Remer EM, Campbell SC, Shoskes DA.
Emphysematous cystitis: a review of 135 cases. BJU Int. 2007 Jul;100(1):17-20.
Thome M, Weil R. Post-translational modifications regulate distinct functions of CARMA1 and BCL10. Trends Immunol. 2007 Jun;28(6):281-288.
Thompson RH, Frank I, Lohse CM, Saad IR, Fergany A, Zincke H, Leibovich BC, Blute ML,
Novick AC. The impact of ischemia time during open nephron sparing surgery on solitary kidneys: a multi-institutional study. J Urol. 2007 Feb;177(2):471-476.
Tian XL, Cheng Y, Zhang T, Liao MLC, Yong SL, Wang QK. Optical mapping of ventricular
arrhythmias in LQTS mice with SCN5A mutation N1325S. Biochem Biophys Res Commun. 2007 Jan 26;352(4):879-883.
Tiu R, Gondek L, O'Keefe C, Maciejewski JP. Clonality of the stem cell compartment during
evolution of myelodysplastic syndromes and other bone marrow failure syndromes.
Leukemia. 2007 Aug;21(8):1648-1657.
Tiu RV, Mountantonakis SE, Dunbar AJ, Schreiber MJ Jr. Tumor lysis syndrome. Semin
Thromb Hemost. 2007 Jun;33(4):397-407.
Togawa D, Kayanja MM, Reinhardt MK, Shoham M, Balter A, Friedlander A, Knoller N, Benzel EC, Lieberman IH. Bone-mounted miniature robotic guidance for pedicle screw and
translaminar facet screw placement: part 2--Evaluation of system accuracy. Neurosurgery.
2007 Feb;60(2 Suppl 1):ONS129-ONS139.
Toms SA, Suh JH, Weil RJ. Choroid plexus metastasis. Urology. 2007 Aug;70(2):370-371.
Tong X, Yang L, Lang JC, Zborowski M, Chalmers JJ. Application of immunomagnetic cell
enrichment in combination with RT-PCR for the detection of rare circulating head and neck
tumor cells in human peripheral blood. Cytometry B Clin Cytom. 2007 Sep;72(5):310-323.
Tong X, Xiong Y, Zborowski M, Farag SS, Chalmers JJ. A novel high throughput
immunomagnetic cell sorting system for potential clinical scale depletion of T cells for
Myles J, Budd GT, Moore HC, Andresen S, Crowe JP. Fluorescence in situ hybridization
(FISH) as primary methodology for the assessment of HER2 status in adenocarcinoma of the breast: a single institution experience. Diagn Mol Pathol. 2007 Dec;16(4):207-210.
Unnithan J, Rini BI. The role of targeted therapy in metastatic renal cell carcinoma.
ScientificWorldJournal. 2007;7:800-807.
Vickers AJ, Bianco FJ, Serio AM, Eastham JA, Schrag D, Klein EA, Reuther AM, Kattan MW, Pontes JE, Scardino PT. The surgical learning curve for prostate cancer control after
radical prostatectomy. J Natl Cancer Inst. 2007 Aug 1;99(15):1171-1177.
Videtic GMM, Adelstein DJ, Mekhail TM, Rice TW, Stevens GHJ, Lee SY, Suh JH. Validation of the RTOG recursive partitioning analysis (RPA) classification for small-cell lung
cancer-only brain metastases. Int J Radiat Oncol Biol Phys. 2007 Jan 1;67(1):240-243.
Vijayaraghavalu S, Raghavan D, Labhasetwar V. Nanoparticles for delivery of
chemotherapeutic agents to tumors. Curr Opin Investig Drugs. 2007 Jun;8(6):477-484.
Vogel J, da Luz Moreira A, Baker M, Hammel J, Einstein D, Stocchi L, Fazio V. CT
enterography for Crohn's disease: Accurate preoperative diagnostic imaging. Dis Colon
Rectum. 2007 Nov;50(11):1761-1769.
Vogelbaum MA. Convection enhanced delivery for treating brain tumors and selected
Vogelbaum MA, Sampson JH, Kunwar S, Chang SM, Shaffrey M, Asher AL, Lang FF,
Croteau D, Parker K, Grahn AY, Sherman JW, Husain SR, Puri RK. Convection-enhanced delivery of cintredekin besudotoc (Interleukin-13-PE38QQR) followed by radiation therapy
with and without temozolomide in newly diagnosed malignant gliomas: Phase 1 study of
final safety results. Neurosurgery. 2007 Nov;61(5):1031-1037; discussion 1037-1038.
Walewska R, Teobald I, Dunnion D, Abdulmajed H, Aldred M, Sadler J, Chapman C, Browning M. Preclinical development of hybrid cell vaccines for multiple myeloma. Eur J
Haematol. 2007 Jan;78(1):11-20.
Wang LX, Shu S, Disis ML, Plautz GE. Adoptive transfer of tumor-primed, in vitro-activated, CD4+ T effector cells (TEs) combined with CD8+ TEs provides intratumoral TE proliferation
and synergistic antitumor response. Blood. 2007 Jun 1;109(11):4865-4876.
Wang X, Yin L, Rao P, Stein R, Harsch KM, Lee Z, Heston WDW. Targeted treatment of prostate cancer. J Cell Biochem. 2007 Oct 15;102(3):571-579.
Wang Z, Yan P, Potter D, Eng C, Huang THM, Lin S. Heritable clustering and pathway
discovery in breast cancer integrating epigenetic and phenotypic data. BMC Bioinformatics.
2007 Feb 1;8:38.
Washenberger CL, Han JQ, Kechris KJ, Jha BK, Silverman RH, Barton DJ. Hepatitis C
virus RNA: Dinucleotide frequencies and cleavage by RNase L. Virus Res. 2007 Dec;130(1-
2):85-95.
Weber F, Xu Y, Zhang L, Patocs A, Shen L, Platzer P, Eng C. Microenvironmental genomic
alterations and clinicopathological behavior in head and neck squamous cell carcinoma.
JAMA. 2007 Jan 10;297(2):187-195.
Weil RJ. When guidelines are not enough. J Clin Oncol. 2007 May 1;25(13):1807-1809.
Weiss PA. Can cancer be diagnosed with a blood test during routine examinations? Clin J
Oncol Nurs. 2007 Dec;11(6):940-941.
Wenzel SE, Balzar S, Ampleford E, Hawkins GA, Busse WW, Calhoun WJ, Castro M, Chung KF, Erzurum S, Gaston B, Israel E, Teague WG, Curran-Everett D, Meyers DA,
Bleecker ER. IL4R alpha mutations are associated with asthma exacerbations and mast
cell/IgE expression. Am J Respir Crit Care Med. 2007 Mar 15;175(6):570-576.
White CL, Whitmore MM, Williams BRG. Enlarged spleens without enlarged lymph nodes in
Wu L, Archacki SR, Zhang T, Wang QK. Induction of high STAT1 expression in transgenic mice with LQTS and heart failure. Biochem Biophys Res Commun. 2007 Jun 29;358(2):449-
bioenergetics in pulmonary artery endothelial cells. Proc Natl Acad Sci U S A. 2007 Jan
23;104(4):1342-1347.
Yao J, Kim TW, Qin J, Jiang Z, Qian Y, Xiao H, Lu Y, Qian W, Gulen MF, Sizemore N, DiDonato J, Sato S, Akira S, Su B, Li X. Interleukin-1 (IL-1)-induced TAK1-dependent
versus MEKK3-dependent NF{kappa}B activation pathways bifurcate at IL-1 receptor-
associated kinase modification. J Biol Chem. 2007 Mar 2;282(9):6075-6089.
Yared JP, Bakri MH, Erzurum SC, Moravec CS, Laskowski DM, Van Wagoner DR, Mascha
E, Thornton J. Effect of dexamethasone on atrial fibrillation after cardiac surgery:
Yee LD, Williams N, Wen P, Young DC, Lester J, Johnson MV, Farrar WB, Walker MJ,
Povoski SP, Suster S, Eng C. Pilot study of rosiglitazone therapy in women with breast
cancer: Effects of short-term therapy on tumor tissue and serum markers. Clin Cancer Res. 2007 Jan 1;13(1):246-252.
Yong SL, Ni Y, Zhang T, Tester DJ, Ackerman MJ, Wang QK. Characterization of the
cardiac sodium channel SCN5A mutation, N(1325)S, in single murine ventricular myocytes. Biochem Biophys Res Commun. 2007 Jan 12;352(2):378-383.
Zbuk KM, Eng C. Predicting response to EGFR-tyrosine kinase inhibitors among diverse
ancestries: just way too polymorphic. Cancer Biol Ther. 2007 Jan;6(1):112-115.
Zbuk KM, Eng C. Hamartomatous polyposis syndromes. Nat Clin Pract Gastroenterol Hepatol. 2007 Sep;4(9):492-502.
Zbuk KM, Patocs A, Shealy A, Sylvester H, Miesfeldt S, Eng C. Germline mutations in
PTEN and SDHC in a woman with epithelial thyroid cancer and carotid paraganglioma. Nat Clin Pract Oncol. 2007 Oct;4(10):608-612.
Zbuk KM, Eng C. Cancer phenomics: RET and PTEN as illustrative models. Nat Rev
Cancer. 2007 Jan;7(1):35-45.
Zelefsky MJ, Kuban DA, Levy LB, Potters L, Beyer DC, Blasko JC, Moran BJ, Ciezki JP,
Zietman AL, Pisansky TM, Elshaikh M, Horwitz EM. Multi-institutional analysis of long-term outcome for stages T1-T2 prostate cancer treated with permanent seed implantation. Int J
Radiat Oncol Biol Phys. 2007 Feb 1;67(2):327-333.
Zembowicz A, Knoepp SM, Bei T, Stergiopoulos S, Eng C, Mihm MC, Stratakis CA. Loss of
expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions. Am J Surg Pathol. 2007
Nov;31(11):1764-1775.
Zeng WF, Navaratne K, Prayson RA, Weil RJ. Aurora B expression correlates with aggressive behaviour in glioblastoma multiforme. J Clin Pathol. 2007 Feb;60(2):218-221.
Zhang M, Mal N, Kiedrowski M, Chacko M, Askari AT, Popovic ZB, Koc ON, Penn MS.
SDF-1 expression by mesenchymal stem cells results in trophic support of cardiac myocytes after myocardial infarction. FASEB J. 2007 Oct;21(12):3197-3207.
Zhang SR, Zhou XQ, Ren X, Wang TT, Yuan MX, Wang Q, Liu JY, Liu MG. Ser217Cys
mutation in the Ig II domain of FGFR3 in a Chinese family with autosomal dominant
achondroplasia. Chin Med J (Engl ). 2007 Jun 5;120(11):1017-1019.
Zhang T, Yong SL, Tian XL, Wang QK. Cardiac-specific overexpression of SCN5A gene
leads to shorter P wave duration and PR interval in transgenic mice. Biochem Biophys Res
Commun. 2007 Apr 6;355(2):444-450.
Zhang X, Chen L, Liu J, Zhao Z, Qu E, Wang X, Chang W, Xu C, Wang QK, Liu M. A novel
DSPP mutation is associated with type II dentinogenesis imperfecta in a Chinese family.
BMC Med Genet. 2007;8:52.
Zhao Z, Xiao Y, Elson P, Tan H, Plummer SJ, Berk M, Aung PP, Lavery IC, Achkar JP, Li L,
Casey G, Xu Y. Plasma lysophosphatidylcholine levels: potential biomarkers for colorectal
Zheng R, Kjaergaard J, Lee WT, Cohen PA, Shu S. Significance of regional draining lymph nodes in the development of tumor immunity: implications for cancer immunotherapy.
Cancer Treat Res. 2007;135:223-237.
Whole Books
Barnett GH. High-Grade Gliomas: Diagnosis and Treatment. Totowa, NJ: Humana Press;
2007.
Hodgson SV, Foulkes WD, Eng C, Maher ER. A Practical Guide to Human Cancer Genetics. 3rd ed. New York, NY: Cambridge University Press; 2007.
Marcus R, Sweetenham JW, Williams ME. Lymphoma : Pathology, Diagnosis and
Treatment. New York, NY: Cambridge University Press; 2007.
Sekeres MA, Kalaycio ME, Bolwell BJ. Clinical Malignant Hematology. New York, NY:
McGraw-Hill Medical; 2007.
Singh AD, Damato BE, Pe'er J, Murphree AL, Perry J. Clinical Ophthalmic Oncology.
Diagnosis and Treatment. Totowa, NJ: Humana Press; 2007:267-282.
Al Mahameed A, Bartholomew JR. Disease of peripheral vessels. In: Topol EJ, ed. Textbook of Cardiovascular Medicine. 3rd ed. Philadelphia, PA: Lippincott Williams &
Wilkins; 2007:1531-1548.
Anderson C, Fleming P, Wilkinson A, Singh AD. Principles of radiation therapy. In: Singh AD, ed. Clinical Ophthalmic Oncology . Philadelphia, PA: Saunders Elsevier; 2007:40-44.
Archacki SR, You SA, Xi Q, Wang Q. Genetics of coronary artery disease and myocardial
infarction: The MEF2 pathway in the endothelium. In: Aird WC, ed. Endothelial Biomedicine.
New York, NY: Cambridge University Press; 2007:847-854.
Attaran M, Gidwani G, Ross J. Surgical techniques for management of anomalies of the
Citardi MJ, Batra PS. Image-guided sinus surgery. In: Kountakis SE, Onerci M, eds. Rhinologic and Sleep Apnea Surgical Techniques. New York, NY: Springer; 2007:189-198.
Citardi MJ. Functional endoscopic sinus surgery. In: Lee KJ, Toh EH, eds. Otolaryngology :
a Surgical Notebook. New York, NY: Thieme; 2007:3-17.
Diagnosis and Treatment. Totowa, NJ: Humana Press; 2007:45-58.
Davis MP, Kuebler KK. Palliative and end-of-life care perspectives. In: Kuebler KK, Heidrich
DE, Esper P, eds. Palliative & End-of-Life Care : Clinical Practice Guidelines. 2nd ed. St. Louis, MO: Saunders Elsevier; 2007:19-32.
Davis MP. Palliation of symptoms associated with hematologic malignancies. In: Sekeres
MA, Kalaycio ME, Bolwell BJ, eds. Clinical Malignant Hematology. New York, NY: McGraw-Hill Medical; 2007:1179-1190.
Dean R, Dunbar CE. Multiple myeloma. In: Boyiadzis.M.M., ed. Hematology-Oncology
Therapy. New York, NY: McGraw-Hill; 2007:360-378.
Ellis SG, Bolwell BJ. Strategies for cytokine modification and stem cell mobilization for acute myocardial infarction. In: Penn MS, ed. Stem Cells and Myocardial Regeneration.
Lieberman IH, Benzel E, Ross ERS. The ideal artificial lumbar intervertebral disc. In: Lewandrowski KU, ed. Spinal Reconstruction: Clinical Examples of Applied Basic Science,
Biomechanics and Engineering. New York, NY: Informa healthcare; 2007:295-301.
Lorenz RR, Strome M. Laryngeal transplantation. In: Lanzetta M, Dubernard JM, Petruzzo
P, eds. Hand Transplantation. New York, NY: Springer; 2007:399-408.
Singh AD, Lewis H, Schachat AP, Peereboom D. Lymphoma of the retina and CNS. In: Singh AD, ed. Clinical Ophthalmic Oncology. Philadelphia, PA: Saunders Elsevier;
Sobecks RM. Clinical deatures and making the diagnosis [Acute lymphoblastic leukemia].
In: Sekeres MA, Kalaycio ME, Bolwell BJ, eds. Clinical Malignant Hematology. New York,
NY: McGraw-Hill Medical; 2007:121-125.
Steinmetz MP, Krishnaney A, Lee JH. Surgical management of convexity meningiomas. In: Badie B, ed. Neurosurgical Operative Atlas. Neuro-Oncology. 2nd ed. New York, NY:
Thieme; 2007:145-152.
Stevens GHJ. General considerations. In: Barnett GH, ed. High-Grade Gliomas: Diagnosis and Treatment. Totowa, NJ: Humana Press; 2007:199-211.
Wang Q, Bond M, Elston RC, Tian XL. Molecular genetics. In: Topol EJ, ed. Textbook of
Cardiovascular Medicine [DVD Only]. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007.
Wang Q, Pyeritz RE, Seidman CE, Basson CT. Genetic studies of myocardial and vascular
disease. In: Topol EJ, ed. Textbook of Cardiovascular Medicine [DVD Only]. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2007.
Zheng R, Kjaergaard J, Lee WT, Cohen PA, Shu S. Significance of regional draining lymph
nodes in the development of tumor immunity: Implications for cancer immunotherapy. In: Leong SPL, ed. Cancer Metastasis and the Lymphovascular System : Basis for Rational
Therapy. New York, NY: Springer; 2007:223-237.
Zhou M, Magi-Galluzzi C, Epstein JI. Non-neoplastic diseases of the urinary bladder. In: